Umbhali: Gregory Harris
Umhla Wokudalwa: 10 Utshazimpuzi 2021
Hlaziya Umhla: 26 Isilimela 2024
Anonim
40K - THE SQUATS RETURN? THEY NEVER WENT AWAY - Warhammer 40,000 Lore/History
Ividiyo: 40K - THE SQUATS RETURN? THEY NEVER WENT AWAY - Warhammer 40,000 Lore/History

Umxholo

I-Lutein luhlobo lwevithamini olubizwa ngokuba yi-carotenoid. Inxulumene ne-beta-carotene kunye nevithamini A. Ukutya okunotye kwi-lutein kubandakanya izikhupha zamaqanda, i-broccoli, isipinatshi, i-kale, umbona, ipepile ye-orenji, iziqhamo ze-kiwi, iidiliya, ijusi yeorenji, zucchini, kunye ne squash. I-Lutein ifunxwa ngcono xa ithathwa ngesidlo esinamafutha aphezulu.

Abantu abaninzi bacinga nge-lutein njenge "vithamini yamehlo." Kuqhelekileyo kuthathwa ngomlomo ukunqanda izifo zamehlo ezinje ngesifo samehlo esikhokelela ekulahlekelweni kombono kubantu abadala (ukoyiswa kwe-macular degeneration okanye i-AMD), kunye neekati. Akukho bungqina bubonakalayo besayensi obuxhasa ukusetyenziswa kwe-lutein kwezinye iimeko.

Uninzi lweevithamini ezininzi zine-lutein. Bahlala bebonelela ngesixa esincinci, njenge-0.25 mg kwithebhulethi nganye.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe UMTHETHO zezi zilandelayo:


Inokwenzeka ukuba isebenze ...

  • Isifo samehlo esikhokelela kwilahleko yombono kubantu abadala (imeko enxulumene nobudala be-macular degeneration okanye i-AMD). Abantu abatya izixa eziphezulu ze-lutein ekudleni kwabo babonakala benomngcipheko ophantsi wokuphuhlisa i-AMD. Kodwa abantu abasele besitya izixa eziphezulu ze-lutein banokungazuzi ngokwandisa ukutya kwabo ngakumbi. Ukuthatha izongezo ze-lutein ukuya kuthi ga kwiinyanga ezingama-36 kunokuphucula iimpawu ze-AMD. Ukuphucuka okukhulu kweempawu kunokubonwa xa i-lutein ithathwa ubuncinci unyaka kwiidosi ezingaphezulu kwe-10 mg, kwaye xa idityaniswa nezinye iivithamini ze-carotenoid. I-Lutein kubonakala ngathi ayigcini i-AMD ekubeni mandundu ekuhambeni kwexesha.
  • Iimpawu. Ukutya izixa eziphezulu ze-lutein kunxulunyaniswa nomngcipheko omncinci wokuphuhlisa i-cataract. Ukuthatha izongezo eziqukethe i-lutein kunye ne-zeaxanthin kunciphisa umngcipheko wokuphuhlisa i-cataract efuna ukususwa kotyando kubantu abatya imali encinci ye-lutein kunye ne-zeaxanthin njengenxalenye yokutya kwabo. Kwakhona, ukuthatha izongezo ze-lutein kubonakala kuphucula umbono kubantu abadala abasele bekrwada kwaye abasele bedla i-lutein eninzi kunye ne-zeaxanthin.

Kusenokwenzeka ukuba ayisebenzi ...

  • Isifo semiphunga esichaphazela iintsana (bronchopulmonary dysplasia). Uphando lubonisa ukuba ukunika abantwana i-lutein kunye ne-zeaxanthin ngomlomo akuwanciphisi amathuba okuphuhlisa i-bronchopulmonary dysplasia.
  • Isifo esibi emathunjini kwiintsana ezingaphambi kwexesha (i-necrotizing enterocolitis okanye i-NEC). Uphando lubonisa ukuba ukunika iintsana zangaphambi kwexesha i-lutein kunye ne-zeaxanthin ngomlomo akuthinteli i-necrotizing enterocolitis.
  • Imeko yamehlo ezuzwe njengelifa ebangela ukungaboni kakuhle ebusuku kunye nokulahleka kombono osecaleni (i-retinitis pigmentosa). Ukuthatha i-lutein ngomlomo akuphuculi umbono okanye ezinye iimpawu kubantu abane-retinitis pigmentosa.
  • Ukuphazamiseka kwamehlo kwiintsana ezingaphambi kwexesha ezinokubangela ubumfama (ukuphinda ubenokubona kwangaphambili). Uphando lubonisa ukuba ukunika iintsana zokuqala i-lutein kunye ne-zeaxanthin ngomlomo akuthinteli i-retinopathy ye-prematurity.

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

  • Yehla kwimemori nakwizakhono zokucinga ezenzeka ngesiqhelo ngobudala. Abantu abadala abatya isixa esikhulu sokutya okuqukethe i-lutein kunye ne-zeaxanthin banokuba nenkumbulo engcono. Iziphumo ze-lutein kwizongezo kwimemori nakwizakhono zokucinga kubantu abadala azicacanga. Olunye uphando lubonisa ukuba ukuthatha i-lutein kunye ne-zeaxanthin njengezincedisi akuphuculi ukuthetha okanye imemori kubantu abadala. Kodwa ukuthatha i-lutein kunye okanye ngaphandle kwe-docosahexaenoic acid (DHA) kunokuphucula ukuthetha kunye nenkumbulo kubafazi abadala.
  • Isifo sikaLou Gehrig (amyotrophic lateral sclerosis okanye i-ALS). Uphando lwakwangoko lubonisa ukuba abantu abatya i-lutein engaphezulu njengenxalenye yokutya kwabo banomngcipheko ophantsi wokufumana i-ALS xa kuthelekiswa nabantu abatya izixa ezantsi ze-lutein.
  • Umhlaza webele. Uphando lubonisa ukuba amanqanaba aphezulu e-lutein egazini adityaniswa nomngcipheko omncinci wokuba nomhlaza wamabele.
  • Isifo sentliziyo. Olunye uphando lwabemi lubonisa ukuba abantu abatya izixa eziphezulu ze-lutein okanye bathathe izongezo ze-lutein banomngcipheko ophantsi weziganeko ezichaseneyo ezinxulumene nentliziyo njengokuhlaselwa kwentliziyo okanye ukubetha. Kodwa uphando lwezonyango lubonisa ukuba ukuthatha i-lutein nge-zeaxanthin ngomlomo akuthinteli ukufa ngenxa yesifo sentliziyo, ukubetha, isifo sentliziyo, okanye iintlungu zesifuba kubantu abadala.
  • Umhlaza womlomo wesibeleko. Uphando lwakwangoko lubonisa ukuba ukutya kancinci kwe-lutein njengenxalenye yokutya akunxulunyaniswa nomngcipheko okhulayo wokuba nomhlaza womlomo wesibeleko.
  • Imeko ezuzwe njengelifa ebangela ukulahleka kombono (choroideremia). Uphando lwakwangoko lubonisa ukuba ukuthatha i-20 mg ye-lutein yonke imihla iinyanga ezi-6 akuphuculi umbono kubantu abane-choroideremia.
  • Umhlaza wekolon, umhlaza we-rectal. Kukho iziphumo eziphikisanayo malunga nokuba ukutya okuqukethe ixabiso eliphezulu le-lutein kunokunciphisa umngcipheko we-colon okanye umdlavuza we-rectal.
  • Seswekile. Olunye uphando lubonisa ukuba amanqanaba asezantsi egazi e-lutein okanye ezinye i-carotenoids zinxulunyaniswa neengxaki zeswekile yegazi. Kwithiyori, ukuthatha i-lutein kunokunciphisa umngcipheko wokuba nesifo seswekile. Nangona kunjalo, olunye uphando lubonisa ukuba ukwanda kokutya kwe-lutein ekutyeni akuwunciphisi umngcipheko wokuba nesifo seswekile.
  • Umbono weengxaki kubantu abanesifo seswekile (isifo seswekile). Uphando lwakwangoko lubonisa ukuba ukuthatha i-lutein akuphuculi umbono kubantu abanesifo seswekile kunye nemeko yamehlo ebizwa ngokuba nesifo seswekile.
  • Umhlaza womqala. Uphando lwakwangoko lubonisa ukuba izixa eziphezulu ze-lutein ekutyeni zinxulunyaniswa nomngcipheko owehlileyo wokuba nomhlaza wesisu.
  • Ukuqhekeka. Abantu abatya izixa eziphezulu ze-lutein ekudleni kwabo ababonakali benomngcipheko ophantsi wokuqhekeka.
  • Umhlaza wesisu. Abantu abatya izixa eziphezulu ze-lutein ekudleni kwabo ababonakali benomngcipheko ophantsi wokuba nomhlaza wesisu.
  • Umhlaza wemiphunga. Obunye ubungqina bokuqala buchaza ukuba amanqanaba asezantsi egazi e-lutein adibene nomngcipheko okhulayo wokuba nomhlaza wemiphunga. Nangona kunjalo, olunye uphando lubonisa ukuba ukuthatha i-lutein akuchaphazeli umngcipheko wokukhula okanye ukubulawa ngumhlaza wemiphunga.
  • Umhlaza oqala kwiiseli ezimhlophe zegazi (engeyo-Hodgkin lymphoma). Uphando lwakwangoko lubonisa ukuba abantu abatya izixa eziphezulu ze-lutein ekudleni kwabo okanye bathathe izongezo ze-lutein banokuba nethuba elisezantsi lokuphuhlisa i-non-Hodgkin lymphoma.
  • Umhlaza wepancreatic. Abantu abatya izixa eziphezulu ze-lutein ekudleni kwabo ababonakali benomngcipheko ophantsi wokuba nomhlaza wepancreatic.
  • Isifo seParkinson. Uphando lwakwangoko lubonisa ukuba izixa eziphezulu ze-lutein ekutyeni akunxulunyaniswa nomngcipheko owehlileyo wokuhlaselwa sisifo seParkinson.
  • Ingxaki yokukhulelwa ephawulwe luxinzelelo lwegazi kunye neprotein kumchamo (pre-eclampsia). Olunye uphando lubonisa ukuba amanqanaba aphezulu egazi e-lutein adibene nomngcipheko omncinci wokukhula koxinzelelo lwegazi xa ukhulelwe. Akucaci ukuba ukuthatha ii-lutein supplements kwehlisa umngcipheko woxinzelelo lwegazi xa ukhulelwe.
  • Umhlaza wedlala lobudoda. Uphando lwakwangoko lubonisa ukuba amanqanaba asezantsi egazi e-lutein awadibananga nomngcipheko okhulayo womhlaza webele.
  • Usulelo lweendlela zomoya. Uphando lwakwangoko lubonisa ukuba amanqanaba aphezulu egazi e-lutein awadibananga nokwehla komngcipheko wosulelo lomoya.
  • Ukuphuhliswa kwamehlo. Amanqanaba aphezulu egazi e-lutein kwabasetyhini abakhulelweyo adityaniswa kumbono ongcono ebantwaneni. Akucaci ukuba ukuthatha i-lutein supplements ngexesha lokukhulelwa kunenzuzo.
  • Uxinzelelo lwamehlo (asthenopia).
  • Ubuhlungu bemisipha obubangelwa kukuzilolonga.
  • Umbono wokuphulukana nokwakhiwa kolwelo phantsi kwenxalenye yamehlo ekuthiwa yirtina.
  • Ezinye iimeko.
Ubungqina obungakumbi buyafuneka ukukala ukusebenza kwe-lutein kwezi zinto zisetyenziswayo.

ILutein yenye yeecarotenoids ezimbini eziphambili ezifumaneka njengombala wombala kwiso lomntu (macula kunye neretina). Kucingelwa ukuba kusebenza njengesihluzi sokukhanya, ukukhusela izicubu zamehlo kumonakalo welanga.

Xa kuthathwa ngomlomo: ULutein unjalo NGOKUKHUSELEKILEYO xa kuthathwa ngomlomo. Ukutya ukuya kuthi ga kwi-20 mg ye-lutein mihla le njengenxalenye yokutya okanye njengesongezelelo kubonakala kukhuselekile.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa kunye nokuncancisa: ULutein unjalo NGOKUKHUSELEKILEYO xa isetyenziswe kwiimali ezifumaneka kukutya.

Abantwana: ULutein unjalo NGOKUKHUSELEKILEYO xa ithathwa ngomlomo ngokwexabiso elifanelekileyo. Imveliso ethile (LUTEINofta, SOOFT Italia SpA) equkethe i-lutein 0.14 mg yonke imihla isetyenziswe ngokukhuselekileyo kwiintsana kwiiveki ezingama-36.

Ayaziwa ukuba le mveliso iyasebenzisana nawaphi na amayeza.

Ngaphambi kokuba uthathe le mveliso, thetha nengcali yezempilo ukuba ngaba uthatha nawaphi na amayeza.
I-Beta-carotene
Ukusebenzisa i-beta-carotene kunye ne-lutein kunokunciphisa inani le-lutein elinokufunxwa ngumzimba. I-lutein inokunciphisa okanye inyuse inani le-beta-carotene umzimba onokuyifunxa.
Vitamin E
Ukuthatha izongezo ze-lutein kunokunciphisa ubuninzi bevithamini E umzimba ubuthatha. Kwithiyori, ukuthatha i-lutein kunye ne-vitamin E kunye kunokunciphisa ukusebenza kwe-vitamin E.
IOlestra (indawo yamanqatha)
Sebenzisa indawo yamanqatha iOlestra kunciphisa ukugxila kwe-lutein yegazi kubantu abasempilweni.
La machiza alandelayo afundwe kuphando lwezesayensi:

NGOMLOMO:
  • Isifo samehlo esikhokelela kwilahleko yombono kubantu abadala (imeko enxulumene nobudala be-macular degeneration okanye i-AMD)Ukuthintela i-AMD, malunga ne-6-12 mg ye-lutein yonke imihla, nokuba kukutya okanye ukongezwa kuye kwasetyenziswa. Ukunciphisa iimpawu ze-AMD, kusetyenziswe i-10-20 mg yemihla ngemihla. Ukunciphisa iimpawu, kusetyenziswe i-10-12 mg ye-lutein yonke imihla.
  • NgamehloUkukhusela i-cataract, malunga ne-6-12 mg ye-lutein yonke imihla, nokuba kukutya okanye ukongezwa kuye kwasetyenziswa. Ukunciphisa iimpawu, kusetyenziswe i-15 mg ye-lutein kathathu ngeveki okanye i-10 mg ye-lutein kunye ne-2 mg ye-zeaxanthin mihla le.
Kukho i-44 mg ye-lutein ngekomityi nganye ye-kale ephekiweyo, i-26 mg ngekomityi yesipinatshi esiphekiweyo, kunye ne-3 mg ngekomityi nganye ye-broccoli.

Zonke-E-Lutein, Beta, epsilon-carotene-3,3’-diol, E-Lutein, Luteina, Lutéine, Lutéine Synthétique, Synthetic Lutein.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.


  1. IMachida N, Kosehira M, Kitaichi N.Iziphumo zeklinikhi yokongezwa kokutya kwe-lutein kunye nokufikeleleka okuphezulu kwe-bio kwi-macular pigment optical density kunye novakalelo lokuthelekisa: Uvavanyo lokuthelekisa lwe-placebo olulawulwa ngokungaboni ngamehlo. Izondlo. Ngo-2020; 12: 2966. Jonga i-abstract.
  2. UZuniga KE, uBhishophu NJ, uTurner AS. I-lutein yokutya kunye ne-zeaxanthin zinxulunyaniswa nememori yokusebenza kubantu abadala. IzeMpilo kaRhulumente kwiZempilo ngo-2020: 1-8. Jonga i-abstract.
  3. . UKobayashi J, uTominaga E, u-Ozeki M, u-Okubo T, uNakagawa K, uMiyazawa T. Uvavanyo olulawulwa ngokungaqhelekanga lokuqulunqwa kwamanzi kwe-lutein ebantwini. I-Biosci Biotechnol Biochem 2019; 83: 2372-4. Jonga i-abstract.
  4. Cota F, Costa S, Giannantonio C, Purcaro V, Catenazzi P, Vento G.Lutein ukongezwa kunye nokubuyiselwa kwengqondo kokungaphambi kwexesha: uhlalutyo lweemeta. J Umama okhulayo umntwana osandul 'ukuzalwa Med 2020: 1-6. Kwi-Intanethi ngaphambi kokuprinta. Jonga i-abstract.
  5. U-Lai JS, uVeetil VO, uLanca C, et al. I-lutein yoomama kunye ne-zeaxanthin yokugxila ngokunxulumene nembonakalo ye-acuity kwiminyaka emi-3 ubudala: Isifundo se-GUSTO. Izondlo 2020; 12: 274. Jonga i-abstract.
  6. UFeng L, uNie K, uJiang H, uFan W. Iziphumo zokuncedisa i-lutein ekwenziweni kweminyaka ehambelana nobudala. I-PLoS One 2019; 14: e022704848. Jonga i-abstract.
  7. I-Ren YB, i-Qi YX, i-Su XJ, i-Luan HQ, i-Sun Q.Ukunyanga okunyanzeliswa yi-lutein kwisongezo sesifo seswekile esinganyangekiyo: isifundo esibuyayo. Amayeza (iBaltimore) 2019; 98: e15404. Jonga i-abstract.
  8. UZhou Y, uWang T, uMeng Q, uZhai S. Umbutho wecarotenoids onomngcipheko wesifo somhlaza esiswini: uhlalutyo lweemeta. Iiklinikhi zeNutr 2016; 35: 109-16. Jonga i-abstract.
  9. U-Chen J, Jiang W, Shao L, Zhong D, Wu Y, Cai J. Umbutho phakathi kokutya i-antioxidants kunye nomngcipheko womhlaza wepancreatic: uhlalutyo lweemeta. I-Int J yokutya iSci Nutriti 2016; 67: 744-53. Jonga i-abstract.
  10. U-Chen F, u-Hu J, u-Liu P, u-Li J, u-Wei Z, u-Liu P.Ukutya kwe-Carotenoid kunye nomngcipheko we-non-Hodgkin lymphoma: uphononongo olucwangcisiweyo kunye neempendulo zedosi-meta-uhlalutyo lwezifundo zokujonga. UAnn Hematol 2017; 96: 957-65. Jonga i-abstract.
  11. Xu J, Ingoma C, Ingoma X, Zhang X, Li X. ICarotenoids kunye nomngcipheko wokophuka: uhlalutyo lweemeta zezifundo zokujonga. I-Oncotarget 2017; 8: 2391-9. Jonga i-abstract.
  12. Abaxhasi be-ET, iDarweesh SK, iBaena CP, et al. Iziphumo ze-lutein kwimpilo ye-cardiometabolic kuyo yonke ikhosi yobomi: uphononongo olucwangcisiweyo kunye nohlalutyo lweemeta. NdinguJ J Clin Nutrr 2016; 103: 481-94. Jonga i-abstract.
  13. I-Wolf-Schnurrbusch UE, i-Zinkernagel MS, i-Munk MR, i-Ebneter A, i-Wolf S.Ukuxhaswa kwe-Oral lutein kwandisa uxinano lwe-macular pigment kunye novakalelo lokuthelekisa kodwa hayi ngokudibanisa ne-polyunsaturated fatty acids. Utyalo mali lweOphthalmol Vis Sci 2015; 56: 8069-74. Jonga i-abstract.
  14. UMa L, uLiu R, uDu JH, et al. I-Lutein, zeaxanthin kunye ne-meso-zeaxanthin yokuncedisa ehambelana ne-macular pigment optical density. Izondlo 2016; 8. IPH: E426. Jonga i-abstract.
  15. UShininojima A, uSawa M, uSekiryu T, et al. Isifundo esilawulwa ngokungahleliwe sokulawulwa kwe-antioxidant kunye ne-lutein ye-chorioretinopathy engapheliyo. I-Ophthalmologica 2017; 237: 159-66. Jonga i-abstract.
  16. Zhang PC, Wu CR, Wang ZL, Wang LY, Han Y, Sun SL, et al. Iziphumo zokuncedisa i-lutein ekusebenzeni ngokubonakalayo kwi-nonproliferative diabetic retinopathy. I-Asia Pac J yeKlinikhi yeNutriti 2017; 26: 406-11. Jonga i-abstract.
  17. U-Evans JR, uLawrenson JG. I-vitamin e-antioxidant kunye ne-mineral supplements yokunciphisa ukuqhubela phambili kwe-macular degeneration. Isiseko sedatha yeCochrane Isityhi 2017; 7: CD000254. Jonga i-abstract.
  18. Ukuhlafuna i-EY, iSanGiovanni JP, uFerris FL, et al. I-Lutein / zeaxanthin yonyango lwe-cataract enxulumene nobudala: I-AREDS2 ingxelo yolingo olungenamkhethe. 4. IJAMA Ophthalmol. NgoJulayi 2013; 131: 843-50. Jonga i-abstract.
  19. Ukuhlafuna i-EY, iiClemons TE, iAgrón E, et al. Iziphumo ze-Omega-3 Fatty Acids, Lutein / Zeaxanthin, okanye enye into yokuNcedisa ngokuNika amandla kwiCognitive Function: I-AREDS2 Randomised Trial Trial. JAMA. Ngo-2015 uAgasti 25; 314: 791-801. Jonga i-abstract.
  20. Iibhondi ze-DE, iHarrington M, i-Worrall BB, et al. Iziphumo zetyathanga elide? -3 fatty acids kunye ne-lutein + zeaxanthin isongezelelo kwiziphumo zentliziyo: iziphumo zesifundo se-Eye-Related Eye Disease Study 2 (AREDS2). JAMA Ngaphakathi Med. Ngo-2014 ngoMeyi; 174: 763-71. Jonga i-abstract.
  21. UWang X, Jiang C, uZhang Y, et al. Indima yokongezwa kwe-lutein kulawulo lokuchaphazeleka okunxulumene nobudala be-macular: Uhlalutyo lweemeta zezilingo ezilawulwa ngokungahleliwe. Ophthalmic Res. Ngo-2014; 52: 198-205. Jonga i-abstract.
  22. UTakeda A, uNyssen OP, uSyed A, et al. I-Vitamin A kunye ne-carotenoids kunye nomngcipheko wesifo sika-Parkinson: ukuphononongwa ngokuchanekileyo kunye nokuhlaziywa kwemeta. Neuroepidemiology. Ngo-2014; 42: 25-38. Jonga i-abstract.
  23. UManzoni P, uGalione R, uBonetti P, et al. I-Lutein kunye ne-zeaxanthin yokuncedisa kwi-preterm ye-low-birth-weight weight neonates in neonatal intensive care units: a multicenter randomized trial trial.NdinguJ Perinatol. Ngo-2013 uJan; 30: 25-32. Jonga i-abstract.
  24. Ma L, Hao ZX, Liu RR, et al. Uhlalutyo lwe-meta-impendulo yohlalutyo lwe-lutein kunye ne-zeaxanthin yokutya ngokunxulumene nomngcipheko we-cataract enxulumene nobudala. Amangcwaba eArch Clin kwi-Ophthalmol. Ngo-2014 uJan; 252: 63-70. Jonga i-abstract.
  25. U-Liu XH, uYu RB, uLiu R, et al. Umanyano phakathi kwe-lutein kunye ne-zeaxanthin kunye nomngcipheko we-cataract: Uhlalutyo lwe-meta. Izondlo. Ngo-2014 uJan 22; 6: 452-65. Jonga i-abstract.
  26. U-Liu R, uWang T, uZhang B, et al. I-Lutein kunye ne-zeaxanthin yokuncedisa kunye nokunxulumana nomsebenzi obonakalayo kwinto enxulumene nobudala be-macular degeneration. Tyala imali kwi-Ophthalmol Vis Sci. Ngo-2014 uDisemba 16; 56: 252-8. Uphononongo. Jonga i-abstract.
  27. I-XX, i-Xing YAM, i-Yu LF, et al. Ukutya kweCarotenoid kunye nomngcipheko wesifo somhlaza: uhlalutyo lweemeta. I-Asia Pac J Umhlaza ngaphambili. Ngo-2013; 14: 1911-8. Jonga i-abstract.
  28. UCui YH, uJing CX, uPan HW. Umbutho wee-antioxidants zegazi kunye neevithamini ezinomngcipheko we-cataract enxulumene nobudala: uhlalutyo lweemeta kwizifundo zokujonga. NdinguJ oNyango lweeKlinikhi. Ngo-2013; 98: 778-86. Jonga i-abstract.
  29. UGarcía-Layana A, uRecalde S, uAlamán AS, uRobredo PF. Iziphumo ze-lutein kunye ne-docosahexaenoic Acid supplementation kwi-macular pigment optical density kwisilingo esilawulwa ngokungahleliwe. Izondlo. Ngo-2013 uFebruwari 15; 5: 543-51. Jonga i-abstract.
  30. UFitzgerald KC, O'Reilly ÉJ, uFondell E, okqhubekayo. Ukungeniswa kwe-vitamin C kunye ne-carotenoids kunye nomngcipheko we-amyotrophic lateral sclerosis: iziphumo ezidibeneyo ezivela kwizifundo ezi-5 zeqela. U-Ann Neurol. Ngo-2013; 73: 236-45. Jonga i-abstract.
  31. Liew SH, Gilbert CE Spector TD Mellerio J Van Kuijk FJ Beatty S Fitzke F Marshall J Hammond CJ. Ubungakanani be-retinal ubukhulu obuhambelana kakuhle ne-macular pigment optical density. Ukuboniswa kwamehlo. Ngo-2006; 82: 915-920.
  32. ULyle, B. J., Mares-Perlman, J. A., Klein, B. E., Klein, R., Palta, M., Bowen, P. E., noGreger, J. L. Serum carotenoids kunye neetopherol kunye neziganeko zekati yenyukliya enxulumene nobudala. NdinguJ J Clin Nutr 1999; 69: 272-277. Jonga i-abstract.
  33. UGoodman, MT, Kiviat, N., McDuffie, K., Hankin, JH, Hernandez, B., Wilkens, LR, Franke, A., Kuypers, J., Kolonel, LN, Nakamura, J., Ing, G. , Isebe, B., Bertram, CC, Kamemoto, L., Sharma, S., kunye noKilleen, J. Umanyano lwee-micronutrients zeplasma ezinobungozi be-dysplasia yomlomo wesibeleko eHawaii. Umhlaza we-Epidemiol. Ngo-1998; 7: 537-544. Jonga i-abstract.
  34. UThurnham, D. I., Northrop-Clewes, C. A., Paracha, P. I., kunye noMcLoone, U. J. Ukubaluleka okunokwenzeka kotshintsho olufanayo kwi-plasma lutein nakwi-retinol kwiintsana zasePakistan ngexesha lehlobo. UBr. J. Nutrr. Ngo-1997; 78: 775-784. Jonga i-abstract.
  35. Pool-Zobel, B. L., Bub, A., Muller, H., Wollowski, I., and Rechkemmer, G. Ukusetyenziswa kwemifuno kunciphisa ukonzakala kwemfuza ebantwini: iziphumo zokuqala zolingo longenelelo lomntu ngokutya okune-carotenoid. ICarcinogenesis 1997; 18: 1847-1850. Jonga i-abstract.
  36. Iliwa, C. L., Flatt, S. W., Wright, F. A., Faerber, S., Newman, V., Kealey, S., kunye noPierce, J. P. Ukuphendula kwe-carotenoids kukungenelela okuphezulu kokutya kwemifuno eyilelwe ukuthintela ukuphindaphinda komhlaza wamabele. Umhlaza we-Epidemiol. Ngo-1997; 6: 617-623. Jonga i-abstract.
  37. Iribarren, C., Folsom, A. R., Jacobs, D. R., Jr., Gross, M. D., Belcher, J. D., kunye no-Eckfeldt, J. H. Umbutho wamanqanaba e-vithamini ye-serum, i-LDL ifaneleke kwi-oxidation, kunye ne-autoantibodies ngokuchasene ne-MDA-LDL ene-carotid atherosclerosis. Isifundo solawulo lwamatyala. Abaphandi be-ARIC. Umngcipheko we-Atherosclerosis kuluntu. IArterioscler iTromb. IVasc. IBiol 1997; 17: 1171-1177. Jonga i-abstract.
  38. IBates, C. J., Chen, S. J., Macdonald, A., kunye noHolden, R. Ubungakanani bevithamini E kunye ne-carotenoid pigment kwii-lens zomntu ezigwenxa, kunye nefuthe lesongezelelo sokutya. I-Int J Vitam. INutr Res. Ngo-1996; 66: 316-321. Jonga i-abstract.
  39. UGartner, C., Stahl, W., kunye no-Sies, H. Ukonyuka okukhethiweyo kwinqanaba le-chylomicron ye-xanthophylls lutein kunye ne-zeaxanthin xa kuthelekiswa ne-beta-carotene emntwini. Int.J.Vitam, iNutr.Res. Ngo-1996; 66: 119-125. Jonga i-abstract.
  40. Yeum, K. J., Booth, S. L., Sadowski, J. A., Liu, C., Tang, G., Krinsky, N. I., kunye noRussell, R. M. Impendulo yeplasma yabantu xa kungeniswa ukutya okulawulwayo okuphezulu kwiziqhamo kunye nemifuno. NdinguJ. Kliniki uNutr 1996; 64: 594-602. Jonga i-abstract.
  41. UMartin, K. R., Failla, M. L., noSmith, J. C., Jr.Beta-carotene kunye ne-lutein bakhusela i-HepG2 iiseli zesibindi zomntu ngokuchasene nomonakalo obangelwe yi-oxidant. UJutut. Ngo-1996; 126: 2098-2106. Jonga i-abstract.
  42. I-Hammond, i-BR, i-Jr, i-Curran-Celentano, i-J, i-Judd, i-S, i-Fuld, i-K., i-Krinsky, i-NI, i-Wooten, i-BR kunye ne-Snodderly, i-DM Ukwahlukana ngokwesondo kwi-macular pigment Iipateni zokutya. Umbono Res. Ngo-1996; 36: 2001-2012. Jonga i-abstract.
  43. IHammond, B. R., Jr., iFuld, K., kunye neCurran-Celentano, J. Macular pigment density kumawele e-monozygotic. Tyala imali kwi-Ophthalmol. Ngo-1995; 36: 2531-2541. Jonga i-abstract.
  44. UNussbaum, J. J., Pruett, R. C., noDelori, F. C. Iimbono zembali. Umbala omthubi we-macular. Iminyaka engama-200 yokuqala. URetina 1981; 1: 296-310. Jonga i-abstract.
  45. Ukuhlafuna i-EY, iiClemons TE, iSanGiovanni JP, et al. Isifo seLiso esiNxulumene neMinyaka yoBudala 2 kwiQela loPhando. I-Lutein + zeaxanthin kunye ne-omega-3 fatty acids ye-macular degeneration ehambelana nobudala: Isifundo se-Eye-Related Eye Disease Study 2 (AREDS2). IJAMA 2013; 309: 2005-2015. Jonga i-abstract.
  46. UMurray, IJ, Makridaki, M., van der Veen, RL, Carden, D., Parry, NR, kunye neBerendschot, ukuxhaswa kweTT Lutein kwisithuba sonyaka omnye kwi-AMD yokuqala kunokuba nefuthe elincinci kubuhle bokubonwayo: i Cacile isifundo. Tyala imali kwi-Ophthalmol. Ngo-2013; 54: 1781-1788. Jonga i-abstract.
  47. IHammond, B. R., Jr., Fletcher, L.M, kunye no-Elliott, J. G. Glare ukukhubazeka, ukubuyiswa kwefotostress, kunye nokwahluka kwe-chromatic: ubudlelwane ne-macular pigment kunye ne-serum lutein kunye ne-zeaxanthin. Tyala imali kwi-Ophthalmol. Ngo-2013; 54: 476-481. Jonga i-abstract.
  48. Loughman, J., Nolan, J. M., Howard, A. N., Connolly, E., Meagher, K., kunye noBeatty, S. Impembelelo yokwandiswa kombala we-macular ekusebenzeni ngokubonakalayo kusetyenziswa iindlela ezahlukeneyo zecarotenoid. Tyala imali kwi-Ophthalmol. Ngo-2012; 53: 7871-7880. Jonga i-abstract.
  49. IHammond, B. R., Jr. kunye noFletcher, L. M. Impembelelo ye-carotenoids lutein kunye ne-zeaxanthin ekusebenzeni ngokubonakalayo: isicelo kwi-baseball. NdinguJ. Clin. Ngo-2012; 96: 1207S-1213S. Jonga i-abstract.
  50. I-SanGiovanni, J. P. kunye neNeuringer, M. Indima yokubeka ye-lutein kunye ne-zeaxanthin njengeearhente zokukhusela ngokuchasene nokubola okuhambelana nobudala: isithembiso semfuza yemolekyuli yokukhokela ubuchwephesha kunye nophando lokuguqula ebaleni. NdinguJ. Clin. Ngo-2012; 96: 1223S-1233S. Jonga i-abstract.
  51. UJohnson, E. J. Indima enokubakho ye-lutein kunye ne-zeaxanthin ekusebenzeni kwengqondo kubantu abadala. NdinguJ. Clin. Ngo-2012; 96: 1161S-1165S. Jonga i-abstract.
  52. UKaya, S., Weigert, G., Pemp, B., Sacu, S., Werkmeister, RM, Dragostinoff, N., Garhofer, G., Schmidt-Erfurth, U., kunye noSchmetterer, L.Ukuthelekiswa kombala we-macular. kwizigulana ezinento yokwenza nobudala be-macular degeneration kunye nezifundo zolawulo olusempilweni- isifundo esisebenzisa ukubonakaliswa kwe-fundral fundus. U-Acta Ophthalmol. Ngo-2012; 90: e399-e403. Jonga i-abstract.
  53. Schweiggert, R. M., Mezger, D., Schimpf, F., Steingass, C. B., noCarle, R. Impembelelo ye-chromoplast morphology kwi-carotenoid bioaccessibility ye-carrot, imango, ipapaya, kunye netumato. Ukutya Chem 12-15-2012; 135: 2736-2742. Jonga i-abstract.
  54. IRos, MM, Bueno-de-Mesquita, HB, Kampman, E., Aben, KK, Buchner, FL, Jansen, EH, van Gils, CH, Egevad, L., Overvad, K., Tjonneland, A., Roswall , N., Boutron-Ruault, MC, Kvaskoff, M., Perquier, F., Kaaks, R., Chang-Claude, J., Weikert, S., Boeing, H., Trichopoulou, A., Lagiou, P, uP. ., Dilis, V., Palli, D., Pala, V., Sacerdote, C., Tumino, R., Panico, S., Peeters, PH, Gram, IT, Skeie, G., Huerta, JM, Barricarte. , A., Quiros, JR, Sanchez, MJ, Buckland, G., Larranaga, N., Ehrnstrom, R., Wallstrom, P., Ljungberg, B., Hallmans, G., Isitshixo, TJ, Allen, NE, Khaw, KT, Wareham, N., Brennan, P., Riboli, E., kunye noKiemeney, LA Plasma carotenoids kunye noxinzelelo lwe-vitamin C kunye nomngcipheko we-urothelial cell carcinoma kwi-European Prospential Investigation kwiCancer and Nutrition. NdinguJ J Clin Nutriti 2012; 96: 902-910. Jonga i-abstract.
  55. UBernstein, PS, Ahmed, F., Liu, A., Allman, S., Sheng, X., Sharifzadeh, M., Ermakov, I., noGellermann, W. Ukucatshulwa kombala we-Macular kubathathi-nxaxheba be-AREDS2: isifundo esincedisayo Izifundo ze-AREDS2 zibhalise kwiziko lemehlo laseMoran. Tyala imali kwi-Ophthalmol. Ngo-2012; 53: 6178-6186. Jonga i-abstract.
  56. Ma, L., Yan, SF, Huang, YM, Lu, XR, Qian, F., Pang, HL, Xu, XR, Zou, ZY, Dong, PC, Xiao, X., Wang, X., Ilanga, I-TT, iDou, i-HL, kunye ne-Lin, i-XM Iziphumo ze-lutein kunye ne-zeaxanthin kwi-macular pigment kunye nomsebenzi obonakalayo kwizigulana ezinesifo esasineminyaka yobudala esihambelana nokubola. I-ophthalmology 2012; 119: 2290-2297. Jonga i-abstract.
  57. Chew, EY, Clemons, T., SanGiovanni, JP, Danis, R., Domalpally, A., McBee, W., Sperduto, R., kunye noFerris, FL Isifundo esiNxulumene neMinyaka yoNyango lweZifo zeLiso 2 (AREDS2): isifundo Uyilo kunye neempawu ezisisiseko (ingxelo ye-AREDS2 inombolo 1). I-ophthalmology 2012; 119: 2282-2289. Jonga i-abstract.
  58. Ma, L., Dou, HL, Huang, YM, Lu, XR, Xu, XR, Qian, F., Zou, ZY, Pang, HL, Dong, PC, Xiao, X., Wang, X., Ilanga, I-TT, kunye neLin, i-XM Ukuphuculwa komsebenzi we-retinal kwimo yobudala enxulumene nobudala emva kokuwohloka kwe-lutein kunye ne-zeaxanthin: ityala elilawulwa ngokungenamsebenzi, elifihliweyo, elilawulwa yi-placebo. Ndingu. J. Opthalmol. Ngo-2012; 154: 625-634. Jonga i-abstract.
  59. UGiordano, P., Scicchitano, P., Locorotondo, M., Mandurino, C., Ricci, G., Carbonara, S., Gesualdo, M., Zito, A., Dachille, A., uCaputo, P., kunye noC. URiccardi, R., Frasso, G., uLassandro, G., Di, Mauro A., kunye neCiccone, MM Carotenoids kunye nomngcipheko wentliziyo. I-Curr. IPhepha. 2012; 18: 5577-5589. Jonga i-abstract.
  60. UGoltz, S. R., Campbell, W. W., Chitchumroonchokchai, C., Failla, M. L., kunye noFerruzzi, M. G. Meal triacylglycerol iprofayile yokumodareyitha ukufakwa emva kwe-carpenoids ebantwini. I-Mol. YeNutr yokutya yokutya. Ngo-2012; 56: 866-877. Jonga i-abstract.
  61. URiccioni, G., Speranza, L., Pesce, M., Cusenza, S., D'Orazio, N., kunye noGlade, M. J. Inoveli ye-phytonutrient enegalelo kukhuselo lwe-antioxidant kwisifo sentliziyo. Isondlo 2012; 28: 605-610. Jonga i-abstract.
  62. Dreher, M.L Pistachio nuts: ukwakheka kunye nezibonelelo ezinokubakho kwezempilo. Isondlo. Ngo-2012; 70: 234-240. Jonga i-abstract.
  63. UTanaka, T., Shnimizu, M., kunye no-Moriwaki, H. Cancer icoprevention yi-carotenoids. Iimolekyuli. Ngo-2012; 17: 3202-3242. Jonga i-abstract.
  64. IVallverdu-Queralt, A., Martinez-Huelamo, M., Arranz-Martinez, S., Miralles, E., kunye neLamuela-Raventos, RM Umahluko kumxholo wecarotenoid weetchups kunye nee-gazpachos nge-HPLC / ESI (Li (+) -MS / MS edityaniswe namandla abo e-antioxidant. J Sci Ukutya kwezolimo. 8-15-2012; 92: 2043-2049. Jonga i-abstract.
  65. UFerguson, uL. R. noSchlothauer, R. C. Indima enokubakho yezixhobo ze-genomics ezinesondlo ekuqinisekiseni ukutya okuphezulu kwezempilo kulawulo lomhlaza: i-broccoli njengomzekelo. I-Mol. YeNutr yokutya yokutya. Ngo-2012; 56: 126-146. Jonga i-abstract.
  66. Sabour-Pickett, S., Nolan, J. M., Loughman, J., kunye noBeatty, S. Ukuphononongwa kobungqina bentsholongwane kwindima yokhuselo lwe-macular carotenoids yokuwohloka okuhambelana nobudala be-macular. I-Mol. YeNutr yokutya yokutya. Ngo-2012; 56: 270-286. Jonga i-abstract.
  67. IHoltan, SG, O'Connor, HM, Fredericksen, ZS, Liebow, M., Thompson, CA, Macon, WR, Micallef, IN, Wang, AH, Slager, SL, Habermann, TM, Call, TG, kunye neCerhan, I-JR yokutya-rhoqo kwimibuzo esekwe kwimibuzo eqikelela amandla e-antioxidant kunye nomngcipheko we-non-Hodgkin lymphoma. Int. J. Umhlaza 9-1-2012; 131: 1158-1168. Jonga i-abstract.
  68. Ucebile, u-SP, uStiles, uW, uGraham-Hoffman, K., uLevin, uM., URuskin, uD., U-Wrobel, uJ., UPaki, u-DW, noThomas, uC. ye-zeaxanthin kunye nomsebenzi obonakalayo kwizigulana ezinesifo se-atrophic ezinxulumene nobudala be-macular degeneration: iZeaxanthin kunye neVisual Function Study (ZVF) FDA IND # 78, 973. Optometry. Ngo-2011; 82: 667-680. Jonga i-abstract.
  69. UPiermarocchi, S., Saviano, S., Parisi, V., Tedeschi, M., Panozzo, G., Scarpa, G., Boschi, G., noLo, uGiudice G.Carotenoids kwisifundo esinxulumene nobudala seMaculopathy Italian Study ( I-CARMIS): iziphumo zeminyaka emibini yesifundo esingahleliwe. I-Eur. J. Epthalmol. Ngo-2012; 22: 216-225. Jonga i-abstract.
  70. UDani, C., Lori, I., Favelli, F., Frosini, S., Messner, H., Wanker, P., De, Marini S., Oretti, C., Boldrini, A., Massimiliano, uC. , IBragetti, P., kunye neGermini, C. I-Lutein kunye ne-zeaxanthin yokuncedisa kwiintsana zangaphambi kokukhusela ukuthintela ukuphinda kubenakho ukubakho ngaphambi kwexesha: isifundo esilawulwa ngokungahleliwe. J. Matern, Ubuthathaka beMetal ye-Neonatal Med. Ngo-2012; 25: 523-527. Jonga i-abstract.
  71. UConnolly, E. E., Beatty, S., Loughman, J., Howard, A. N., Louw, M. S., noNolan, J. M.Ukuxhaswa nazo zontathu ii-macular carotenoids: impendulo, uzinzo, kunye nokhuseleko. Tyala imali kwi-Ophthalmol. Ngo-2011; 52: 9207-9217. Jonga i-abstract.
  72. Romagnoli, C., Giannantonio, C., Cota, F., Papacci, P., Vento, G., Valente, E., Purcaro, V., noCosta, S. Isifundo esinokwenzeka, esingenamkhethe, esingaboniyo ngokuthelekisa i-lutein kwi-placebo yokunciphisa ukwenzeka kunye nobukrakra be-retinopathy yobudala bokuqala. J. Matern, Ubuthathaka beMetal ye-Neonatal Med. 2011; 24 iSuppl 1: 147-150. Jonga i-abstract.
  73. I-Thyagarajan, B., Meyer, A., Smith, LJ, Beckett, WS, Williams, OD, Gross, MD, kunye noJacobs, DR, Jr.Ukugxininiswa kwe-carumenoid yeserum kuqikelela ukusebenza kwemiphunga kubantu abadala abancinci: iCoronary Artery Risk Development in Abantu abadala abancinci (CARDIA). NdinguJ. Clin. Ngo-2011; 94: 1211-1218. Jonga i-abstract.
  74. Ma, L., Dou, HL, Wu, YQ, Huang, YM, Huang, YB, Xu, XR, Zou, ZY, kunye neLin, i-XM Lutein kunye nokutya kwe-zeaxanthin kunye nomngcipheko wokuwohloka okuhambelana nobudala be-macular: uphononongo lwenkqubo kunye nohlalutyo lweemeta. UBr. J. Nutrr. Ngo-2012; 107: 350-359. Jonga i-abstract.
  75. I-Weigert, G., Kaya, S., Pemp, B., Sacu, S., Lasta, M., Werkmeister, RM, Dragostinoff, N., Simader, C., Garhofer, G., Schmidt-Erfurth, U. kunye no-A. , kunye noSchmetterer, L.Iziphumo zokuncedisa i-lutein kwi-macular pigment optical density kunye ne-visual acuity kwizigulana ezinokonakala okuhambelana nobudala be-macular. Tyala imali kwi-Ophthalmol. Ngo-2011; 52: 8174-8178. Jonga i-abstract.
  76. I-Sasamoto, Y., Gomi, F., Sawa, M., Tsujikawa, M., kunye noNishida, K. Iziphumo zokuncedisa i-lutein yonyaka we-1 kulungelelwaniso lwe-macular pigment optical function and visual function. Ingcwaba leArch.Clin. Exp. IOphthalmol. Ngo-2011; 249: 1847-1854. Jonga i-abstract.
  77. URubin, LP, Chan, GM, Barrett-Reis, BM, Fulton, AB, Hansen, RM, Ashmeade, TL, Oliver, JS, Mackey, AD, Dimmit, RA, Hartmann, EE, kunye no-Adamkin, isiphumo se-DH sonyango lwe-carotenoid kwiiplasma carotenoids, ukudumba kunye nokukhula okubonakalayo kwiintsana ezizelwe ngaphambi kwexesha. J Perinatol. Ngo-2012; 32: 418-424. Jonga i-abstract.
  78. URavindran, RD, Vashist, P., Gupta, SK, Oselula, IS, Maraini, G., Camparini, M., Jayanthi, R., John, N., Fitzpatrick, KE, Chakravarthy, U., Ravilla, TD, kunye noFletcher, umbutho we-AE oguqukayo we-vitamin C kunye ne-cataract kubantu abadala e-India. Ophthalmology 2011; 118: 1958-1965. Jonga i-abstract.
  79. I-Saxena, S., Srivastava, P., kunye neKhanna, V. K. Antioxidant supplementation iphucula i-platelet membrane fluidity kwi-idiopathic retinal periphlebitis (isifo se-Eales). J. Ocul, iParmacol kunye noTher. Ngo-2010; 26: 623-626. Jonga i-abstract.
  80. UZeimer, M.B, Kromer, I., Spital, G., Lommatzsch, A., noPauleikhoff, D. I-telangiectasia ye-Macular: iipateni zokuhanjiswa kwe-macular pigment kunye nokuphendula kwisongezelelo. Iretina 2010; 30: 1282-1293. Jonga i-abstract.
  81. Bartlett, H., Howells, O., kunye no-Eperjesi, F. Indima yovavanyo lwe-macular pigment kwinkqubo yeklinikhi: uphononongo. Iklinikhi. Ngo-2010; 93: 300-308. Jonga i-abstract.
  82. ICapeding, R., Gepanayao, C. P., Calimon, N., Lebumfacil, J., Davis, A. M., Stouffer, N., kunye noHarris, B. J. Isondlo. J. Ngo-2010; 9: 22. Jonga i-abstract.
  83. UBerson, EL, Rosner, B., Sandberg, MA, Weigel-DiFranco, C., Brockhurst, RJ, Hayes, KC, Johnson, EJ, Anderson, EJ, Johnson, CA, Gaudio, AR, Willett, WC, kunye noSchaefer Uvavanyo lweklinikhi lwe-lutein kwizigulana ezine-retinitis pigmentosa efumana ivithamini A. Arch.Ophthalmol. Ngo-2010; 128: 403-411. Jonga i-abstract.
  84. Takeda, S., Masuda, Y., Usuda, M., Marushima, R., Ueji, T., Hasegawa, M., kunye noMaruyama, C. Iziphumo ze-mayonnaise kwi-postprandial serum lutein / zeaxanthin kunye ne-beta-carotene abantu. UJutut Sci. Vitaminol. (Tokyo) 2009; 55: 479-485. Jonga i-abstract.
  85. Teixeira, VH, Valente, H. F., Casal, S. I., Marques, A. F., and Moreira, P. A. I-Antioxidants ayikuthinteli ukwenza umthambo emva kokuzilolonga kwaye inokulibazisa ukubuyiswa kwemisipha. IMidlalo yeSci Exerc. Ngo-2009; 41: 1752-1760. Jonga i-abstract.
  86. IPerrone, S., Longini, M., Marzocchi, B., Picardi, A., Bellieni, CV, Proietti, F., Rodriguez, A., Turrisi, G., kunye neBuonocore, G. Iziphumo ze-lutein kuxinzelelo lwe-oxidative. kwikota elisanda kuzalwa: isifundo somqhubi. Neonatology. Ngo-2010; 97: 36-40. Jonga i-abstract.
  87. Ma, L., Lin, X. M., Zou, Z. Y., Xu, X. R., Li, Y., kunye no-Xu, R. Unyango lwe-lutein lweeveki ezili-12 luphucula umsebenzi wokubonwayo kubantu baseTshayina abanesibonakaliso sokukhanya esikude kwikhompyuter. UBr. J. Nutrr. Ngo-2009; 102: 186-190. Jonga i-abstract.
  88. Yagi, A., Fujimoto, K., Michihiro, K., Goh, B., Tsi, D., noNagai, H. Iziphumo zokuncedisa i-lutein kukhathala olubonakalayo: Uhlalutyo lwe-psychophysiological. Iapile. Ngo-2009; 40: 1047-1054. Jonga i-abstract.
  89. I-Vojnikovic, B., Kovacevic, D., Njiric, S., kunye neCoklo, M. Iziphumo zexesha elide ezinxulumene nonyango lokudodobala okuhambelana nobudala kunye ne-prednisolone acetate-ekhethekileyo ibhekisa kutshintsho olubonakalayo lomhlaba. Ikhonkco yeAntropol. Ngo-2008; 32: 351-353. Jonga i-abstract.
  90. Cho, E., Hankinson, S. E., Rosner, B., Willett, W. C., noColditz, G. A. Ukufundwa okulindelweyo kokutya kwe-lutein / zeaxanthin kunye nomngcipheko wokudodobala okunxulumene nobudala be-macular. NdinguJ. Clin. Ngo-2008; 87: 1837-1843. Jonga i-abstract.
  91. UDherani, M., Murthy, GV, Gupta, SK, Oselula, IS, Maraini, G., Camparini, M., Ixabiso, GM, John, N., Chakravarthy, U., kunye noFletcher, AE Amanqanaba egazi ngevithamini C , Iicarotenoids kunye ne-retinol zinxulunyaniswa ngokuchasene ne-cataract kubemi baseMntla Indian. Tyala imali kwi-Ophthalmol. Ngo-2008; 49: 3328-3335. Jonga i-abstract.
  92. UMoeller, SM, Voland, R., Tinker, L., Blodi, BA, Klein, ML, Gehrs, KM, Johnson, EJ, Snodderly, DM, Wallace, RB, Chappell, RJ, Parekh, N., Ritenbaugh, C ., Kunye neMares, Imanyano ye-JA phakathi kweminyaka yobudala enxulumene nekatala yenyukliya kunye ne-lutein kunye ne-zeaxanthin ekutyeni nakwi-serum kwi-Carotenoids kwi-Study-Related Eye Disease Study, i-Ancillary Study ye-Women's Health Initiative. IArch Ophthalmol. Ngo-2008; 126: 354-364. Jonga i-abstract.
  93. Bartlett, H. E. kunye no-Eperjesi, F.Uvavanyo olulawulwa ngokungahleliwe oluphanda isiphumo se-lutein kunye ne-antioxidant yokutya okunezondlo kwimisebenzi ebonakalayo emehlweni asempilweni. KwiKlinikhi. Ngo-2008; 27: 218-227. Jonga i-abstract.
  94. Adackapara, C. A., Sunness, J. S., Dibernardo, C. W., Melia, B. M., kunye noDagnelie, G. Ukubekwa phambili kwe-cystoid macular edema kunye nozinzo kwi-oct retinal thickness emehlweni ane-retinitis pigmentosa ngexesha lokuvavanywa kwe-lutein yeeveki ezingama-48. Iretina 2008; 28: 103-110. Jonga i-abstract.
  95. Thomson, C.A, Stendell-Hollis, N. R., Rock, C. L., Cussler, E. C., Flatt, S. W., kunye noPierce, J. P. Plasma kunye ne-carotenoids yokutya zinxulunyaniswa noxinzelelo lwe-oxidative kubasetyhini ababekhe banyangwa umhlaza webele. Umhlaza we-Epidemiol. 2007; 16: 2008-2015. Jonga i-abstract.
  96. I-LaRowe, T. L., Mares, J. A., Snodderly, D. M., Klein, M. L., Wooten, B. R., kunye noChappell, R. Macular pigment density kunye ne-maculopathy enxulumene nobudala kwiiCarotenoids kwizifundo ezinxulumene nobudala besifo seLiso. Isifundo esincedisayo sephulo lezempilo labasetyhini. Ophthalmology 2008; 115: 876-883. Jonga i-abstract.
  97. San Giovanni, JP, Chew, EY, Clemons, TE, Ferris, FL, III, Gensler, G., Lindblad, AS, Milton, RC, Seddon, JM, and Sperduto, RDUbudlelwane be-carotenoid yokutya kunye nevithamini A, E , kunye no-C ukungenisa ngokunxulumene nobudala be-macular degeneration kwisifundo sokulawulwa kwetyala: Ingxelo ye-AREDS ye-Nombolo 22. Arch.Ophthalmol. Ngo-2007; 125: 1225-1232. Jonga i-abstract.
  98. URobman, L., Vu, H., Hodge, A., Tikellis, G., Dimitrov, P., McCarty, C., noGuymer, R.Izidlo lutein, zeaxanthin, kunye namafutha kunye nokuqhubela phambili kwe-macular enxulumene nobudala. ukonakala. Ngaba. J. Opthalmol. Ngo-2007; 42: 720-726. Jonga i-abstract.
  99. UTan, J. S., Wang, J., uMkhukula, V., Rochtchina, E., Smith, W., kunye noMitchell, P.Izinto zokulwa ne-antioxidants kunye nexesha elide lokudodobala okunxulumene nobudala be-macular: iBlue Mountains Eye Study. Ophthalmology 2008; 115: 334-341. Jonga i-abstract.
  100. UGouado, I., Schweigert, F. J., Ejoh, R. A., Tchouanguep, M. F., kunye no-Camp, J. V. Amanqanaba enkqubo ye-carotenoids evela kwimango kunye nepapaya edliwe ngeendlela ezintathu (ijusi, isilayidi esitsha nesomileyo). I-Eur. J. Clin, iNutr. Ngo-2007; 61: 1180-1188. Jonga i-abstract.
  101. URicher, S., Devenport, J., kunye noLang, J. C. LAST II: Iimpendulo ezahlukileyo zethutyana ze-macular pigment optical density kwizigulana ezinedrophic ezinxulumene nobudala be-macular degeneration kukutya okune-xanthophylls. Ugqirha wamehlo. Ngo-2007; 78: 213-219. Jonga i-abstract.
  102. Palombo, P., Fabrizi, G., Ruocco, V., Ruocco, E., Fluhr, J., Roberts, R., kunye noMorganti, P.Ukuxhamla kweziphumo zexesha elide zokudityaniswa komlomo / unyango lwe-antioxidant kunye ne-carotenoids I-lutein kunye ne-zeaxanthin kulusu lomntu: isifundo esilawulwa yimfama kabini. Ulusu lwePhemacol. IPhysol 2007; 20: 199-210. Jonga i-abstract.
  103. Cangemi, F. E. TOZAL Study: isifundo esilawulayo solawulo lwe-antioxidant yomlomo kunye ne-omega-3 yokuxhasa i-AMD eyomileyo. I-BMC Ophthalmol 2007; 7: 3. Jonga i-abstract.
  104. Bartlett, H. E. kunye no-Eperjesi, F. Iziphumo ze-lutein kunye ne-antioxidant yokutya okunezondlo ekuchaseni ubuntununtunu kwizifo ezinxulumene nobudala be-macular: ityala elilawulwa ngokungahleliwe. I-Eur. J. Clin, iNutr. Ngo-2007; 61: 1121-1127. Jonga i-abstract.
  105. Hozawa, A., Jacobs, DR, Jr., Steffes, MW, Gross, MD, Steffen, LM, kunye no-Lee, ubudlelwane be-DH bokujikeleza ukugxila kwe-carotenoid ngamanqaku amaninzi okuvuvukala, uxinzelelo lwe-oxidative, kunye ne-endothelial dysfunction: i-Coronary Artery Risk Ukuphuhliswa kwaBantu abaDala abaDala (i-CARDIA) / iNdlela yaBadala yaBantu abaDala kwiiNtsholongwane (YALTA). Iiklinikhi Chem 2007; 53: 447-455. Jonga i-abstract.
  106. URosenthal, JM, Kim, J., de, Monasterio F., Thompson, DJ, Bone, RA, Landrum, JT, de Moura, FF, Khachik, F., Chen, H., Schleicher, RL, Ferris, FL, I-III, kunye ne-Chew, i-EY yokufunda ngokuhambelana nedosi yokuncedisa i-lutein kubantu abaneminyaka engama-60 nangaphezulu. Tyala imali kwi-Ophthalmol. Ngo-2006; 47: 5227-5233. Jonga i-abstract.
  107. I-Trumbo, i-P. Kunye ne-Ellwood, i-K.C Lutein kunye ne-zeaxanthin yokungena kunye nomngcipheko wokudodobala kwe-macular kunye ne-cataract: uvavanyo kusetyenziswa inkqubo yovavanyo olusekwe kubungqina bokutya kunye noLawulo lweziyobisi kumabango ezempilo. NdinguJ. Clin. Ngo-2006; 84: 971-974. Jonga i-abstract.
  108. Schalch, W., Cohn, W., Barker, FM, Kopcke, W., Mellerio, J., Bird, AC, Robson, AG, Fitzke, FF, no van Kuijk, FJ Xanthophyll ukuqokelelwa kwiretina yomntu ngexesha lokudibanisa I-lutein okanye i-zeaxanthin-isifundo se-LUXEA (LUtein Xanthophyll Eye Accumulation). IArch. Ibhayoloji. 2-15-2007; 458: 128-135. Jonga i-abstract.
  109. Moeller, SM, Parekh, N., Tinker, L., Ritenbaugh, C., Blodi, B., Wallace, RB, kunye noMares, JA Imibutho phakathi kwexesha eliphakathi elinxulumene nokwehla kwe-macular kunye ne-lutein kunye ne-zeaxanthin kwi-Carotenoids kwi-Age- Isifundo esimalunga nezifo zamehlo (CAREDS): isifundo esincedisayo sePhulo lezeMpilo laBasetyhini. IArch Ophthalmol. Ngo-2006; 124: 1151-1162. Jonga i-abstract.
  110. UShao, A. noHathcock, J. N. Uvavanyo lomngcipheko we-carotenoids lutein kunye ne-lycopene. Ulawulo lweToxicol Pharmacol 2006; 45: 289-298. Jonga i-abstract.
  111. Umkhukula, V., Rochtchina, E., Wang, J., Mitchell, P., noSmith, W. Lutein kunye ne-zeaxanthin yokutya ukutya kunye nokuwohloka okuhambelana nobudala be-macular. UBr. J. Opthalmol. Ngo-2006; 90: 927-928. Jonga i-abstract.
  112. U-Bahrami, H., Melia, M., no-Dagnelie, G. Lutein supplementation kwi-retinitis pigmentosa: Uvavanyo lwembono esekwe kwi-PC kuvavanyo lwe-placebo olulawulwa kabini olungenamakhonkco [NCT00029289]. I-BMC yeOththalmol. Ngo-2006; 6: 23. Jonga i-abstract.
  113. UHerron, K. L., McGrane, M. M., Waters, D., Lofgren, I. E., Clark, R. M., Ordovas, J. M., noFernandez, M. L. I-ABCG5 polymorphism inegalelo kwimpendulo nganye kwi-cholesterol yokutya kunye ne-carotenoids kumaqanda. J Amanqatha 2006; 136: 1161-1165. Jonga i-abstract.
  114. UAndersen, uLF, uJacobs, u-R., uJr., UGross, uM. D., uSchreiner, uPJ, uDale, uWilliam O., kunye no-Lee, D. H. Imibutho emide phakathi kwesalathiso sobunzima bomzimba kunye ne-serum carotenoids: isifundo seCARDIA. Br J Amanqaku 2006; 95: 358-365. Jonga i-abstract.
  115. UZhao, X., Aldini, G., Johnson, EJ, Rasmussen, H., Kraemer, K., Woolf, H., Musaeus, N., Krinsky, NI, Russell, RM, kunye noYeum, KJ Ukulungiswa kwe-DNA ye-lymphocyte umonakalo ngokuxhaswa kwe-carotenoid kubafazi be-postmenopausal. NdinguJ J Clin 2006; 83: 163-169. Jonga i-abstract.
  116. Coyne, T., Ibiebele, TI, Baade, PD, Dobson, A., McClintock, C., Dunn, S., Leonard, D., kunye noShaw, J. Isifo seswekile kunye ne-serum carotenoids: iziphumo zabantu kufunda eQueensland, e-Australia. NdinguJ J Clin Nutriti 2005; 82: 685-693. Jonga i-abstract.
  117. Ito, Y., Wakai, K., Suzuki, K., Ozasa, K., Watanabe, Y., Seki, N., Ando, ​​M., Nishino, Y., Kondo, T., Ohno, Y., kunye noTamakoshi, A. Ukufa komhlaza wemiphunga kunye nenqanaba le-serum ye-carotenoids, i-retinol, i-tocopherols, kunye ne-folic acid emadodeni nakwabasetyhini: isifundo solawulo lwamatyala esihleli kuFundo lwe-JACC. J Epidemiol. Ngo-2005; 15 iSuppl 2: S140-S149. Jonga i-abstract.
  118. Morganti, P., Fabrizi, G., kunye noBruno, C. Iziphumo zokukhusela ii-antioxidants zomlomo kulusu nakwiliso. Ulusu. Ngo-2004; 3: 310-316. Jonga i-abstract.
  119. Natarajan, L., Rock, CL, Major, JM, Thomson, CA, Caan, BJ, Flatt, SW, Chilton, JA, Hollenbach, KA, Newman, VA, Faerber, S., Ritenbaugh, CK, Gold, E. , Stefanick, ML, Jones, LA, Marshall, JR, kunye noPierce, JP ngokubaluleka kokusebenzisa iindlela ezininzi zovavanyo lokutya. Epidemiology 2004; 15: 738-745. Jonga i-abstract.
  120. UDorgan, JF, Boakye, NA, Uloyiko, TR, Schleicher, RL, Helsel, W., Anderson, C., Robinson, J., Guin, JD, Lessin, S., Ratnasinghe, LD, kunye noTangrea, JA Serum carotenoids kunye ne-alpha-tocopherol kunye nomngcipheko womhlaza wesifo se-nonmelanoma. Umhlaza we-Epidemiol. Ngo-2004; 13: 1276-1282. Jonga i-abstract.
  121. van der Horst-Graat JM, Kok, F.J, kunye no-Schouten, E. G. Plasma carotenoid egxile ngokunxulumene nosulelo olunamandla lokuphefumla kubantu abadala. Br J Amanqaku 2004; 92: 113-118. Jonga i-abstract.
  122. I-Molldrem, K. L., Li, J., Simon, P. W., kunye neTanumihardjo, S. A. Lutein kunye ne-beta-carotene evela kwi-lutein equlathe iminqathe etyheli ayifumaneki ebantwini. NdinguJ. Clin. Ngo-2004; 80: 131-136. Jonga i-abstract.
  123. UDwyer, J.H., Paul-Labrador, M.J, Fan, J., Shircore, A. M., Merz, C.N, kunye noDwyer, K. M.Ukuqhubela phambili kwe-carotid intima-media thickness and plasma antioxidants: Isifundo seLos Angeles Atherosclerosis. IArterioscler iTromb. IVasc. IBiol 2004; 24: 313-319. Jonga i-abstract.
  124. Upritchard, J. E., Schuurman, C. R., Wiersma, A., Tijburg, L. B., Coolen, S. A., Rijken, P. J., kunye noWiseman, S. A. Ukusasazeka okuxhaswe ngeedosi ezilinganiselweyo ze-vitamin E kunye ne-carotenoids kunciphisa i-lipid peroxidation kubantu abadala abasempilweni. NdinguJ J weeKlinikhi ezingama-2003; 78: 985-992. Jonga i-abstract.
  125. Bartlett, H. kunye no-Eperjesi, F. Uvavanyo olulawulwa ngokungahleliwe oluphanda umphumo wokuncedisa okunomsoco ekusebenzeni okubonakalayo kwinto eqhelekileyo, kunye nezifo ezinxulumene nobudala be-macular zichaphazela amehlo: ukuyila kunye nendlela yokusebenza [ISRCTN78467674]. Isondlo. J. 10-10-2003; 2: 12. Jonga i-abstract.
  126. I-Abnet, CC, Qiao, YL, Dawsey, SM, Buckman, DW, Yang, CS, Blot, WJ, Dong, ZW, Taylor, PR, kunye noMark, SD Ukufundwa okulindelekileyo kwe-serum retinol, beta-carotene, beta-cryptoxanthin, kunye ne-lutein / zeaxanthin kunye ne-esophageal kunye ne-gastric cancer. Ulawulo lweZibangela zoMhlaza 2003; 14: 645-655. Jonga i-abstract.
  127. I-Kiokias, S. kunye no-Gordon, M. H. Ukongezwa kokutya kunye nomxube wendalo we-carotenoid kunciphisa uxinzelelo lwe-oxidative. Ikliniki ye-Eur. J. Nutr. Ngo-2003; 57: 1135-1140. Jonga i-abstract.
  128. UWilliam, M. A., Woelk, G. B., King, I. B., Jenkins, L., kunye noMahomed, K. Plasma carotenoids, retinol, tocopherols, kunye lipoproteins kwi-preeclamptic kunye ne-normotensive abafazi abakhulelweyo baseZimbabwe. NdinguJ Hypertens. Ngo-2003; 16: 665-672. Jonga i-abstract.
  129. UGale, C. R., Hall, N. F., Phillips, D. I., kunye noMartyn, C. N. Lutein kunye ne-zeaxanthin kunye nomngcipheko wokuwohloka okuhambelana nobudala be-macular. Tyala imali kwi-Ophthalmol. Ngo-2003; 44: 2461-2465. Jonga i-abstract.
  130. Cardinault, N., Gorrand, J. M., Tyssandier, V., Grolier, P., Rock, E., kunye no-Borel, P. Ukuxhaswa kwexesha elifutshane kunye ne-lutein kuchaphazela i-biomarkers yesimo se-lutein ngokufanayo kwizifundo ezincinci nezindala. Yazisa iGerontol. Ngo-2003; 38: 573-582. Jonga i-abstract.
  131. I-Bone, R. A., Landrum, J. T., Guerra, L.H, kunye neRuiz, C. A. Lutein kunye ne-zeaxanthin izongezo zokutya zonyusa uxinano lwe-macular pigment kunye ne-serum ye-carotenoids ebantwini. UJutut. Ngo-2003; 133: 992-998. Jonga i-abstract.
  132. I-Djuric, Z., Uhley, VE, Naegeli, L., Lababidi, S., Macha, S., kunye noHeilbrun, LK Plasma carotenoids, tocopherols, kunye namandla e-antioxidant kwisifundo se-12 seveki sokungenelela ukunciphisa amafutha kunye / okanye amandla ungeniso. Isondlo 2003; 19: 244-249. Jonga i-abstract.
  133. UFalsini, B., Piccardi, M., Iarossi, G., Fadda, A., Merendino, E., kunye noValentini, P. Impembelelo yokongezwa kwexesha elifutshane le-antioxidant ekusebenzeni kwe-macular kwi-maculopathy enxulumene nobudala: isifundo somqhubi kubandakanya Uvavanyo lwe-electrophysiologic. Ophthalmology 2003; 110: 51-60. Jonga i-abstract.
  134. Olmedilla, B., Granado, F., Blanco, I., kunye noVaquero, M. Lutein, kodwa hayi i-alpha-tocopherol, ukongezwa kuphucula ukusebenza kokubonakalayo kwizigulana ezinekati ejongene nobudala: i-2-y kabini-blind, placebo- isifundo somqhubi esilawulwayo. Isondlo 2003; 19: 21-24. Jonga i-abstract.
  135. I-Berendschot, T., Broekmans, W. M., Klopping-Ketelaars, IA, Kardinaal, A. F., Van, Poppel G., kunye noVan, uNorren D. Ilensi yokuguga ngokunxulumene nokuchazwa kwesondlo kunye nezinto ezinokubangela umngcipheko kwinto enxulumene nobudala bekatsi. IArch Ophthalmol. Ngo-2002; 120: 1732-1737. Jonga i-abstract.
  136. UBowen, P. E., Herbst-Espinosa, S. M., Hussain, E. A., kunye noStacewicz-Sapuntzakis, M. Ukwazisa akuthinteli ukubakho kwe-lutein ebantwini. UJutut. Ngo-2002; 132: 3668-3673. Jonga i-abstract.
  137. IBroekmans, WM, Berendschot, TT, Klopping-Ketelaars, IA, de Vries, AJ, Goldbohm, RA, Tijburg, LB, Kardinaal, AF, kunye nevan van Poppel, G. Macular pigment density on serum and adipose tissue concentrations of lutein kunye ne-serum yoxinzelelo lwe-zeaxanthin. NdinguJ. Clin. 2002; 76: 595-603. Jonga i-abstract.
  138. Snellen, E. L., Verbeek, A. L., Van Den Hoogen, G. W., Cruysberg, J. R., kunye noHoyng, C. B. Neovascular ehambelana nobudala be-macular degeneration kunye nolwalamano lwayo kwi-antioxidant intake. UMthetho weOphthalmol. Ngo-2002; 80: 368-371. Jonga i-abstract.
  139. UValero, M. P., Fletcher, A. E., De Stavola, B. L., Vioque, J., kunye noAlepuz, V. C. I-Vitamin C inxulunyaniswa nomngcipheko wokunciphisa isifo se-cataract kubemi beMeditera. UJutut. Ngo-2002; 132: 1299-1306. Jonga i-abstract.
  140. I-Eichler, O., i-Sies, H., kunye ne-Stahl, W. Amanqanaba afanelekileyo e-lycopene, i-beta-carotene kunye ne-lutein ekhusela ngokuchasene ne-UVB radiation kwi-fibroblastst yabantu. Ifoto yePhotobiol. 2002; 75: 503-506. Jonga i-abstract.
  141. UDuncan, JL, Aleman, TS, Gardner, LM, De Castro, E., Amanqaku, DA, Emmons, JM, Bieber, ML, Steinberg, JD, Bennett, J., Stone, EM, MacDonald, IM, Cideciyan, AV , Maguire, MG, kunye noJacobson, SG Macular pigment kunye ne-lutein supplementation kwi-choroideremia. Ex. Amehlo Res. Ngo-2002; 74: 371-381. Jonga i-abstract.
  142. Iliwa, C. L., Thornquist, M. D., Neuhouser, M. L., Kristal, A. R., Neumark-Sztainer, D., Cooper, D. A., Patterson, R. E., kunye noCheskin, L. J. Ukutya kunye nendlela yokuphila enxulumene ne-lutein egazini nakwizidlo. UJutut. Ngo-2002; 132: 525S-530S. Jonga i-abstract.
  143. UTaylor, A., Jacques, PF, Chylack, LT, Jr., Hankinson, SE, Khu, PM, Rogers, G., Friend, J., Tung, W., Wolfe, JK, Padhye, N., kunye noWillett. , WC Ukuthatha ixesha elide iivithamini kunye neecarotenoids kunye nokungahambi kakuhle kwecortical kunye ne-posterior subcapsular lens opacities. NdinguJ. Clin. Ngo-2002; 75: 540-549. Jonga i-abstract.
  144. I-Curran-Celentano, J., Hammond, BR, Jr., Ciulla, TA, Cooper, DA, Pratt, LM, kunye neDanis, RB Unxibelelwano phakathi kokutya okutyayo, ukugxila kwe-serum, kunye ne-retinal ye-lutein kunye ne-zeaxanthin kubantu abadala kwi-Midwest Inani labemi. NdinguJ. Clin. 2001; 74: 796-802. Jonga i-abstract.
  145. Gale, C. R., Hall, N. F., Phillips, D. I., kunye noMartyn, C. N. Plasma iivithamini ze-antioxidant kunye ne-carotenoids kunye ne-cataract enxulumene nobudala. Ophthalmology 2001; 108: 1992-1998. Jonga i-abstract.
  146. UJacques, PF, Chylack, LT, Jr., Hankinson, SE, Khu, PM, Rogers, G., Friend, J., Tung, W., Wolfe, JK, Padhye, N., Willett, WC, kunye noTaylor, A. Ukutya ixesha elide kwezondlo kunye ne-opacities yeelensi zenyukliya ezineminyaka yobudala. IArch Ophthalmol. 2001; 119: 1009-1019. Jonga i-abstract.
  147. IJunghans, A., Sies, H., kunye ne-Stahl, W. Macular pigment lutein kunye ne-zeaxanthin njengesihluzi sokukhanya esiluhlaza esifundwe kwi-liposomes. IArch. Ibhayoloji. 7-15-2001; 391: 160-164. Jonga i-abstract.
  148. I-Aleman, TS, Duncan, JL, Bieber, ML, De Castro, E., Marks, DA, Gardner, LM, Steinberg, JD, Cideciyan, AV, Maguire, MG, noJacobson, SG Macular pigment kunye ne-lutein supplementation kwi-retinitis pigmentosa kunye ne-Usher syndrome. Tyala imali kwi-Ophthalmol. 2001; 42: 1873-1881. Jonga i-abstract.
  149. UDwyer, JH, Navab, M., Dwyer, KM, Hassan, K., Ilanga, P., Shircore, A., Hama-Levy, S., Hough, G., Wang, X., Drake, T., IMerz, i-CN, kunye neFogelman, i-AM Oxygenated carotenoid lutein kunye nokuqhubela phambili kwe-atherosclerosis yasekuqaleni: isifundo seLos Angeles atherosclerosis. Ukujikeleza kwe-6-19-2001; 103: 2922-2927. Jonga i-abstract.
  150. O'Neill, ME, Carroll, Y., Corridan, B., Olmedilla, B., Granado, F., Blanco, I., van den, Berg H., Hininger, I., Rousell, AM, Chopra, M ., Southon, S., kunye noThurnham, DI Idatha yaseYurophu ye-carotenoid yokuvavanya ukungena kwe-carotenoid kunye nokusetyenziswa kwayo kuphononongo lokuthelekiswa kwamazwe amahlanu. Br J Amanqaku 2001; 85: 499-507. Jonga i-abstract.
  151. Olmedilla, B., Granado, F., Southon, S., Wright, AJ, Blanco, I., Gil-Martinez, E., Berg, H., Corridan, B., Roussel, AM, Chopra, M., kunye no-A. kunye noThurnham, i-DI Serum egxile kwi-carotenoids kunye neevithamini A, E, kunye no-C kwizifundo zolawulo ezivela kumazwe amahlanu aseYurophu. Br J Amanqaku 2001; 85: 227-238. Jonga i-abstract.
  152. Mares-Perlman, JA, Fisher, AI, Klein, R., Palta, M., Block, G., Millen, AE, kunye noWright, JD Lutein kunye ne-zeaxanthin ekutyeni nakwi-serum kunye nokunxibelelana kwabo ne-maculopathy enxulumene nobudala. kuvavanyo lwesithathu lwezempilo kuzwelonke kunye novavanyo lwesondlo. Ndingu. J. Epidemiol. 3-1-2001; 153: 424-432. Jonga i-abstract.
  153. UBeatty, S., Murray, I. J., Henson, D. B., uCarden, D., Koh, H., noBoulton, M. E. Macular pigment kunye nomngcipheko wokuwohloka okuhambelana nobudala kwizifundo ezivela kubemi baseMantla Yurophu. Tyala imali kwi-Ophthalmol. 2001; 42: 439-446. Jonga i-abstract.
  154. I-Bone, R. A., Landrum, J. T., Mayne, S. T., Gomez, C. M., Tibor, S. E., kunye ne-Twaroska, E. E. I-pigment ye-Macular emehlweni abo banikelayo nangaphandle kwe-AMD: isifundo solawulo lwamatyala. Tyala imali kwi-Ophthalmol. 2001; 42: 235-240. Jonga i-abstract.
  155. Chopra, M., O'Neill, M. E., Keogh, N., Wortley, G., Southon, S., noThurnham, D. I. Impembelelo yokunyuka kweziqhamo kunye nokutya kwemifuno kwiplasma kunye neepoprotein carotenoids kunye ne-LDL oxidation kubantu abatshayayo nabangatshayiyo. KwiKlinikhi. Ngo-2000; 46: 1818-1829. Jonga i-abstract.
  156. Berendschot, T., Goldbohm, R. A., Klopping, W. A., van de, Kraats J., van Norel, J., kunye no-van Norren, D. Impembelelo yokongezwa kwe-lutein kwi-macular pigment, kuvavanywa ngeendlela ezimbini zeenjongo. Tyala imali kwi-Ophthalmol. Ngo-2000; 41: 3322-3326. Jonga i-abstract.
  157. I-Bone, R. A., Landrum, J., Dixon, Z., Chen, Y., kunye neLlerena, C. M. Lutein kunye ne-zeaxanthin emehlweni, i-serum kunye nokutya kwezifundo zabantu. Ex. Amehlo Res. Ngo-2000; 71: 239-245. Jonga i-abstract.
  158. Rapp, L. M., Maple, S. S., kunye no-Choi, J. H. Lutein kunye ne-zeaxanthin yokugxininisa kwiimbumba zangaphandle zeentonga ezivela kwi-retina kunye ne-peripheral retina yabantu. Tyala imali kwi-Ophthalmol. Ngo-2000; 41: 1200-1209. Jonga i-abstract.
  159. ISumantran, V. N., Zhang, R., Lee, D. S., kunye noWicha, M. S. Ukwahlula okwahlukileyo kwe-apoptosis kwinto yesiqhelo xa ithelekiswa ne-mammary epithelium ye-lutein kunye ne-retinoic acid. Umhlaza we-Epidemiol. Ngo-2000; 9: 257-263. Jonga i-abstract.
  160. het Hof, K. H., Tijburg, L. B., Pietrzik, K., kunye neWeststrate, J. A. Impembelelo yokondla imifuno eyahlukeneyo kumanqanaba e-plasma ye-carotenoids, i-folate kunye ne-vitamin C. Iziphumo zokuphazamiseka kwematriki yemifuno. Br. J Nutriti 1999; 82: 203-212. Jonga i-abstract.
  161. I-Siems, W. G., Sommerburg, O., kunye ne-van Kuijk, F. J.Lycopene kunye ne-beta-carotene zibola ngokukhawuleza kune-lutein kunye ne-zeaxanthin xa ichanabeka kwi-pro-oxidants ezahlukeneyo kwi-vitro. Ii-Biofactors 1999; 10 (2-3): 105-113. Jonga i-abstract.
  162. UWright, A. J., Hughes, D. A., Bailey, A.L, kunye noSouthon, S. Beta-carotene kunye ne-lycopene, kodwa hayi i-lutein, ukongezwa kuyatshintsha iprofayili ye-asidi yeplasma ye-acid yabantu abangatshayiyo abasempilweni. J kwiKlinikhi yaseMed 1999; 134: 592-598. Jonga i-abstract.
  163. UCastenmiller, J. J., Lauridsen, S. T., Dragsted, L. O., het Hof, K. H., Linssen, J. P., kunye neNtshona, uC. E. beta-carotene ayitshintshi amanqaku e-enzymatic and nonenzymatic antioxidantJ Nutriti 1999; 129: 2162-2169. Jonga i-abstract.
  164. ISommerburg, O. G., Siems, W. G., Hurst, J. S., Lewis, J. W., Kliger, D. S., kunye no-van Kuijk, F. J. Lutein kunye ne-zeaxanthin banxulunyaniswa ne-photoreceptors kwi-retina yomntu. Ikhonkco. Ngo-1999; 19: 491-495. Jonga i-abstract.
  165. Paetau, I., Rao, D., Wiley, E. R., Brown, E. D., kunye noClevidence, B. A. Carotenoids kwiiseli zomntu ze-buccal mucosa emva kwe-4 wk yokongezwa ngejusi yetumato okanye izongezo ze-lycopene. NdinguJ J Clin Nutr 1999; 70: 490-494. Jonga i-abstract.
  166. I-Richer, S. ARMD -ulingo (uchungechunge lwamatyala) idatha yokungenelela kwendalo. J Ndingu-Optom. Assoc 1999; 70: 24-36. Jonga i-abstract.
  167. I-Handelman, G. J., Nightingale, Z. D., Lichtenstein, A. H., Schaefer, E. J., kunye neBlumberg, J. B. Lutein kunye ne-zeaxanthin egxile kwi-plasma emva kokongezwa kokutya kunye ne-yolk yeqanda. NdinguJ. Clin. Ngo-1999; 70: 247-251. Jonga i-abstract.
  168. UGarcia-Closas, R., Agudo, A., Gonzalez, C. A., kunye noRiboli, E.Ukungeniswa kwee-carotenoids ezithile kunye ne-flavonoids kunye nomngcipheko womhlaza wemiphunga kwabasetyhini e-Barcelona, ​​eSpain. Umhlaza weNutriti 1998; 32: 154-158. Jonga i-abstract.
  169. Li, L., Chen, CY, Aldini, G., Johnson, EJ, Rasmussen, H., Yoshida, Y., Niki, E., Blumberg, JB, Russell, RM, kunye noYeum, uKJ Ukongezwa kunye ne-lutein okanye i-lutein kunye nezicatshulwa zeti eluhlaza azitshintshi uxinzelelo lwe-oxidative kubantu abadala abonele ngokwaneleyo. J Isondlo. Ngo-2010; 21: 544-549. Jonga i-abstract.
  170. Isono, H. P., Liu, D., kunye neLam, D. S. Ukulungiswa kwendlela yokuphila, ukutya okunesondlo kunye neevithamini zokongeza ukwanda okuhambelana nobudala be-macular. U-Acta Ophthalmol. Ngo-2013; 91: 6-11. Jonga i-abstract.
  171. UJohnson, E. J., McDonald, K., Caldarella, S. M., Chung, H. Y., Troen, A. M., kunye no Snodderly, D. M. Iziphumo zokuqonda zolingo lokuhlola i-docosahexaenoic acid kunye ne-lutein supplementation kubafazi abadala. Isondlo Neurosci 2008; 11: 75-83. Jonga i-abstract.
  172. Johnson, E. J., Chung, H. Y., Caldarella, S. M., kunye no Snodderly, D. M. Impembelelo ye-lutein eyongezelelweyo kunye ne-docosahexaenoic acid kwi-serum, lipoproteins, kunye ne-macular pigmentation. NdinguJ J Clin Nutr 2008; 87: 1521-1529. Jonga i-abstract.
  173. Ito, Y., Wakai, K., Suzuki, K., Tamakoshi, A., Seki, N., Ando, ​​M., Nishino, Y., Kondo, T., Watanabe, Y., Ozasa, K., kunye no-Ohno, Y. I-Serum carotenoids kunye nokusweleka kumhlaza wemiphunga: isifundo solawulo lwamatyala esidlekweni sophando lwaseJapan lweCohort (JACC). Umhlaza weSci. Ngo-2003; 94: 57-63. Jonga i-abstract.
  174. I-Kawabata, F. kunye neTsuji, T.Iziphumo zokongezwa kokutya ngokudityaniswa kweoyile yeentlanzi, ukukhutshwa kwebilberry, kunye ne-lutein kwiimpawu ezizimeleyo ze-asthenopia ebantwini. I-Biomed Res 2011; 32: 387-393. Jonga i-abstract.
  175. U-Eliassen, AH, Hendrickson, SJ, Brinton, LA, Buring, JE, Campos, H., Dai, Q., Dorgan, JF, Franke, AA, Gao, YT, Goodman, MT, Hallmans, G., Helzlsouer, KJ , Hoffman-Bolton, J., Hulten, K., Sesso, HD, Sowell, AL, Tamimi, RM, Toniolo, P., Wilkens, LR, Winkvist, A., Zeleniuch-Jacquotte, A., Zheng, W. (1). , kunye noHankinson, SE Ukujikeleza i-carotenoids kunye nomngcipheko womhlaza wamabele: Uhlalutyo oluhlanganisiweyo lwezifundo ezisibhozo ezinokubakho. J Natl. Umhlaza Inst. 12-19-2012; 104: 1905-1916. Jonga i-abstract.
  176. I-Aune, D., Chan, DS, Vieira, AR, Navarro Rosenblatt, DA, Vieira, R., Greenwood, DC, kunye neNorat, T.Izidlo xa kuthelekiswa nokuxinana kwegazi kwe-carotenoids kunye nomngcipheko womhlaza wamabele: uphononongo olucwangcisiweyo kunye nemeta- Uhlalutyo lwezifundo ezinokwenzeka. NdinguJ J Clin Nutriti 2012; 96: 356-373. Jonga i-abstract.
  177. Hu, F., Wang, Yi B., Zhang, W., Liang, J., Lin, C., Li, D., Wang, F., Pang, D., kunye noZhao, Y. ICarotenoids kunye nomhlaza webele. Umngcipheko: Uhlalutyo lweemeta kunye neemeta-regression. Umhlaza webele Res. Unyango. Ngo-2012; 131: 239-253. Jonga i-abstract.
  178. Chong, E. W., Wong, T. Y., Kreis, A. J., Simpson, J. A., noGuymer, R.H.Izinto zokulwa ne-antioxidants kunye nothintelo lokuqala lokuwohloka okuhambelana nobudala be-macular: uphononongo lwenkqubo kunye nohlalutyo lweemeta. BMJ 10-13-2007; 335: 755. Jonga i-abstract.
  179. ICardinault, N., Tyssandier, V., Grolier, P., Winklhofer-Roob, BM, Ribalta, J., Bouteloup-Demange, C., Rock, E., kunye no-Borel, P. Ukuthelekiswa kweempendulo ze-postprandial chylomicron carotenoid kwizifundo ezincinci nezindala. I-Eur. J. iNutr. Ngo-2003; 42: 315-323. Jonga i-abstract.
  180. Heinrich, U., Gartner, C., Wiebusch, M., Eichler, O., Sies, H., Tronnier, H., kunye noStahl, W.Ukuxhaswa nge-beta-carotene okanye inani elifanayo le-carotenoids ekhuselekileyo ikhusela abantu I-erythema ebangelwe yi-UV. J Utyando 2003; 133: 98-101. Jonga i-abstract.
  181. Malila, N., Virtamo, J., Virtanen, M., Pietinen, P., Albanes, D., kunye noTeppo, L.Izidlo kunye ne-serum alpha-tocopherol, beta-carotene kunye ne-retinol, kunye nomngcipheko wesifo somhlaza kumadoda. abatshayayo. I-Eur. J. Clin, iNutr. Ngo-2002; 56: 615-621. Jonga i-abstract.
  182. IHininger, IA, Meyer-Wenger, A., Moser, U., Wright, A., Southon, S., Thurnham, D., Chopra, M., van den, Berg H., Olmedilla, B., Favier, I-AE, kunye neRoussel, AM Akukho ziphumo zibalulekileyo ze-lutein, i-lycopene okanye i-beta-carotene yokuncedisa kwiimpawu zebhayoloji zoxinzelelo lwe-oxidative kunye ne-LDL oxidizability kwizifundo zabantu abadala ezisempilweni. J Ndingu-Coll Nutrut 2001; 20: 232-238. Jonga i-abstract.
  183. Yamini, S., West, KP, Jr., Wu, L., Dreyfuss, ML, Yang, DX, kunye noKhatry, SK Amanqanaba ajikelezayo e-retinol, tocopherol kunye ne-carotenoid eNepali abasetyhini abakhulelweyo nabasemva kokubeleka abalandela i-beta-carotene yexesha elide kunye ne-vitamin A yokuncedisa. I-Eur. J. Clin, iNutr. 2001; 55: 252-259. Jonga i-abstract.
  184. van den Berg H. Iziphumo ze-lutein kukufakwa kwe-beta-carotene kunye nokuqaqamba. I-Int J Vitam Nutr Res 1998; 68: 360-5. Jonga i-abstract.
  185. IAlbanes D, uVirtamo J, Taylor PR, et al. Iziphumo zokuncedisa i-beta-carotene, ukutshaya icuba, kunye nokusela utywala kwi-serum carotenoids kwi-Alpha-Tocopherol, Beta-Carotene Cancer Study Prevention. NdinguJ J Clin Nutr 1997; 66: 366-72. Jonga i-abstract.
  186. UReboul E, uThap S, uPerrot E, et al. Iziphumo ze-antioxidants eziphambili zokutya (i-carotenoids, i-gamma-tocopherol, i-polyphenols, kunye ne-vitamin C) kwi-alpha-tocopherol yokufakwa. I-Eur J yeklinikhi yeNutrr 2007; 61: 1167-73. Jonga i-abstract.
  187. IBloomer RJ, uFry A, uSchilling B, uChiu L, et al. Ukuxhaswa kwe-Astaxanthin akukuthinteli ukwenzakala kwemisipha kulandela ukuzivocavoca umzimba kumadoda aqeqeshwe kukuxhathisa. I-Int J yezeMidlalo yokuSebenza ngeZondlo 2005; 15: 401-12. Jonga i-abstract.
  188. UParisisi V, uTedeschi M, uGallinaro G, et al. IiCarotenoids kunye ne-antioxidants ezinxulumene nobudala be-maculopathy yokufunda e-Italiya: Uhlengahlengiso lwe-multifocal electroretinogram emva konyaka omnye. Ophthalmology 2008; 115: 324-33. Jonga i-abstract.
  189. UThurmann PA, uSchalch W, uAebischer JC, et al. IPlasma kinetics ye-lutein, zeaxanthin, kunye ne-3-dehydro-lutein emva kwedosi ezininzi zomlomo zesongezelelo se-lutein. NdinguJ J Clin Nutriti 2005; 82: 88-97. Jonga i-abstract.
  190. U-Lee EH, uFaulhaber D, uHanson KM, et al. Ukutya i-lutein kunciphisa i-radiation ye-radiation ebangelwa kukudumba kunye nokucinezelwa komzimba. J Tyala iDermatol 2004; 122: 510-7. Jonga i-abstract.
  191. IGruber M, uChappell R, uMillen A, et al. I-Correlates ye-serum lutein + zeaxanthin: iziphumo ezivela kuPhando lweSizwe lwezeMpilo kunye noVavanyo lwezeMpilo. J Amanqatha 2004; 134: 2387-94. Jonga i-abstract.
  192. I-Bowen PE, i-Herbst-Espinosa SM, i-Hussain EA, i-Stacewicz-Sapuntzakis M. I-Esterification ayithinteli ukubakho kwe-lutein ebantwini. J Amanqatha 2002; 132: 3668-73. Jonga i-abstract.
  193. UKoh HH, uMurray IJ, uNolan D, et al. Iiplasma kunye neempendulo ze-macular kwisongezo se-lutein kwizifundo ezingena-maculopathy ezinxulumene nobudala: isifundo somqhubi. Ukucaciswa kwamehlo Res 2004; 79: 21-27. Jonga i-abstract.
  194. UChung HY, uRasmussen HM, uJohnson EJ. I-Lutein bioavailability iphezulu ukusuka kumaqanda atyetyiswe nge-lutein kunakwizincedisi kunye nesipinatshi emadodeni. J Amanqatha 2004; 134: 1887-93. Jonga i-abstract.
  195. IShuphupp C, u-Olano-Martin E, uGerth C, et al. I-Lutein, zeaxanthin, i-macular pigment, kunye nomsebenzi wokubonwayo kwizigulana zabantu abadala be-cystic fibrosis. NdinguJ J Clin Nutriti 2004; 79 1045-52. Jonga i-abstract.
  196. van Leeuwen R, Boekhoorn S, Vingerling JR, et al. Ukutya ukutya kwee-antioxidants kunye nomngcipheko wokudodobala macular. IJAMA 2005; 294: 3101-7. Jonga i-abstract.
  197. I-Knekt P, uRitz J, uPereira MA, et al. Iivithamini ze-antioxidant kunye nomngcipheko wesifo sentliziyo: uhlalutyo oluhlanganisiweyo lwamaqela angama-9. NdinguJ J Clin Nutriti 2004; 80: 1508-20. Jonga i-abstract.
  198. UOlmedilla B, uGranado F, uSouthon S, et al. I-multicentre yaseYurophu, indawo elawulwa yi-placebo elawulwa yi-alpha-tocopherol, ioyile yesundu ene-carotene, i-lutein okanye i-lycopene: uhlalutyo lweempendulo ze-serum. Iiklinikhi zeSci (Lond) 2002; 102: 447-56. Jonga i-abstract.
  199. Ukhetho E, uSeddon JM, uRosner B, et al. Ukufundelwa kokutya iziqhamo, imifuno, iivithamini, kunye ne-carotenoids kunye nomngcipheko we-maculopathy enxulumene nobudala. IArch Ophthalmol 2004; 122: 883-92. Jonga i-abstract.
  200. UMontonen J, uKnkt P, uJarvinen R, uReunanen A.Ukutya ukutya okune-antioxidant kunye nomngcipheko wohlobo lweswekile 2. Unonophelo lweSwekile 2004; 27: 362-6. Jonga i-abstract.
  201. UGoodman GE, uSchaffer S, u-Omenn GS, kunye no-al. Umanyano phakathi komngcipheko womhlaza wemiphunga kunye neprostate, kunye ne-serum micronutrients: iziphumo kunye nezifundo ezifundwe kwi-beta-carotene kunye ne-retinol yesilingo sokusebenza. Umhlaza we-Epidemiol Biomarkers Prev 2003; 12: 518-26. Jonga i-abstract.
  202. Isityebi S, Stiles W, Statkute ​​L, et al. Imaski ephindwe kabini, elawulwa yi-placebo, yolingo olungenamkhethe lwe-lutein kunye ne-antioxidant yokuncedisa kungenelelo lwe-atrophic enxulumene nobudala be-macular degermation: isifundo seVeterans LAST (Isilingo seLutein Antioxidant Supplement Trial). I-Optometry 2004; 75: 216-30. Jonga i-abstract.
  203. UHammond BR Jr, uJohnson EJ, uRussell RM, et al. Ukuguqulwa kokutya koxinzelelo lwe-macular pigment yabantu. Tyala imali kwi-Ophthalmol Vis Sci 1997; 38: 1795-801 .. Jonga i-abstract.
  204. Isifundo seLiso lokuLawulwa kwezifo zeSifo seLiso. Ubume be-antioxidant kunye ne-neovascular age-related degeneration. IArch Ophthalmol 1993; 111: 104-9 .. Jonga i-abstract.
  205. UDagnelie G, uZorge IS, uMcDonald TM. I-Lutein iphucula ukusebenza kokubonakalayo kwezinye izigulana ezinokonakala kwe-retinal: isifundo somqhubi nge-Intanethi. I-Optometry 2000; 71: 147-64 .. Jonga i-abstract.
  206. UJohnson EJ, uHammond BR, uYeum KJ, et al. Ubudlelwane phakathi kwe-serum kunye ne-tishu egxile kwi-lutein kunye ne-zeaxanthin kunye ne-macular pigment density. NdinguJ J Clin Nutriti 2000; 71: 1555-62 .. Jonga i-abstract.
  207. Yeum KJ, Ahn SH, Rupp de Paiva SA, okqhubekayo. Ukulungelelaniswa phakathi kokugxilwa kwe-carotenoid kwi-serum kunye nezihlunu eziqhelekileyo zesifuba se-adipose yabasetyhini abanesifo esibuhlungu sesifuba okanye umhlaza webele. J Nutriti 1998; 128: 1920-6 .. Jonga i-abstract.
  208. UKim MK, Ahn SH, uLee-Kim. Ubudlelwane be-serum alpha-tocopherol, i-carotenoids kunye ne-retinol ngomngcipheko womhlaza wamabele. Ukutya okunesondlo 2001; 21: 797-809.
  209. Umkhukula V, uSmith W, uWang JJ, et al. Ukutya ukutya okuchaseneyo ne-antioxidant kunye neziganeko zemaculopathy ezinxulumene nokufikisa: i-Blue Mountains Eye Study. I-Ophthalmology 2002; 109: 2272-8 .. Jonga i-abstract.
  210. USchunemann HJ, uGrant BJ, uFreudenheim JL, et al. Ubudlelwane benqanaba le-serum ye-antioxidant iivithamini C kunye no-E, i-retinol kunye ne-carotenoids ezinomsebenzi we-pulmonary kuluntu ngokubanzi. NdinguJ J wokuKhathalela uKhathalelo ngeMed 2001; 163: 1246-55 .. Jonga abstract.
  211. IVandenLangenberg GM, Mares-Perlman JA, Klein R, okqhubekayo. Unxibelelwano phakathi kokungena kwi-antioxidant kunye ne-zinc kunye neminyaka emi-5 yezehlo ezinxulumene nobudala besifo seBeverver Dam. NdinguJ Epidemiol 1998; 148: 204-14. Jonga i-abstract.
  212. IRoodenburg AJ, Leenen R, van het Hof KH, et al. Inani lamafutha ekudleni lichaphazela ukungafumaneki kwe-lutein esters kodwa hayi nge-alpha-carotene, beta-carotene, kunye nevithamini E ebantwini. NdinguJ J Clin 2000; 71: 1187-93. Jonga i-abstract.
  213. UMores-Perlman JA, uBrady WE, uKlein R, et al. Iserum antioxidants kunye nokudodobala okunxulumene nobudala be-macular kwisifundo esisekwe kulawulo lwamatyala. IArch Ophthalmol 1995; 113: 518-23. Jonga i-abstract.
  214. IGossage C, iDeyhim M, iMoser-Veillon PB, et al. Iziphumo zokongezwa kwe-beta-carotene kunye nokwanyisa kwi-carotenoid metabolism kunye nokwanda kwe-mitogenic T-lymphocyte. NdinguJ J Clin 2000; 71: 950-5. Jonga i-abstract.
  215. USeddon JM, uAjani UA, uSperduto R, et al. I-carotenoids yokutya, iivithamini A, C, kunye no-E, kunye nokudodobala okuhambelana nobudala obuhambelana nobudala. IJAMA 1994; 272: 1413-20. Jonga i-abstract.
  216. UMores-Perlman JA, uBrady WE, uKlein BE, et al. I-Serum carotenoids kunye ne-tocopherols kunye nobukhali benyukliya kunye ne-cortical opacities. Tyala imali kwi-Ophthalmol Vis Sci 1995; 36: 276-88. Jonga i-abstract.
  217. Isilayidi ML, uPotter JD, uCoates A, et al. Ukutya kwezityalo kunye nomhlaza wekolon: uvavanyo lokutya okuthile kunye nezondlo ezinxulumene nazo (eUnited States). Ulawulo lweZibangela zoMhlaza 1997; 8: 575-90. Jonga i-abstract.
  218. I-Steinmetz KA, uMbumbi JD. Imifuno, iziqhamo, kunye nomhlaza. I. Izifo zengqondo. Umhlaza oBanga uLawulo 1991; 2: 325-57. Jonga i-abstract.
  219. Isilayidi ML, uBenson J, uCurtin K, et al. IiCarotenoids kunye nomhlaza wekolon. NdinguJ J Clin 2000; 71: 575-82. Jonga i-abstract.
  220. IHammond BR Jr, iWooten BR, iSnodderly DM, et al. Ukuxinana kwelensi yekristali yomntu inxulumene ne-macular pigment carotenoids, lutein kunye ne-zeaxanthin. I-Optom Vis Sci 1997; 74: 499-504. Jonga i-abstract.
  221. ISommerburg O, Keunen JE, intaka AC, van Kuijk FJ. Iziqhamo kunye nemifuno eyimithombo ye-lutein kunye ne-zeaxanthin: i-pigment macular emehlweni abantu. UBr J Ophthalmol 1998; 82: 907-10. Jonga i-abstract.
  222. UTeikari JM, uVirtamo J, uRautalahti M, et al. Ukuxhaswa kwexesha elide kunye ne-alpha-tocopherol kunye ne-beta-carotene kunye ne-cataract ehambelana nobudala. UMthetho weOphthalmol Scand 1997; 75: 634-40. Jonga i-abstract.
  223. UTeikari JM, uRautalahti M, Haukka J, et al. Isiganeko sokusebenza kwecataract kubantu baseFinland abatshayayo abangachaphazelekiyo yi-alpha tocopherol okanye izongezo ze-beta carotene. J Epidemiol yoLuntu yezeMpilo 1998; 52: 468-72. Jonga i-abstract.
  224. Lyle BJ, Mares-Perlman JA, Klein BE, et al. Ukuthatha i-Antioxidant kunye nomngcipheko weziganeko ezinxulumene nobudala benyukliya kwiSifundo seLiso leDama laseBeverver. NdinguJ Epidemiol 1999; 149: 801-9. Jonga i-abstract.
  225. UChasan-Taber L, uWillett WC, uSeddon JM, et al. Ukuchaneka Isifundo esinokubakho sokufakwa kwe-carotenoid kunye ne-vitamin A kunye nomngcipheko wokukhutshwa kwe-cataract kubafazi base-US. NdinguJ J Clin Nutriti 1999; 70: 509-16. Jonga i-abstract.
  226. UBrown L, uRimm EB, uSeddon JM, et al. Isifundo esinokwenzeka sokutya kwe-carotenoid kunye nomngcipheko wokukhutshwa kwe-cataract kumadoda ase-US. NdinguJ J Clin Nutr 1999; 70: 517-24. Jonga i-abstract.
  227. Lyle BJ, Mares-Perlman JA, Klein BE, et al. Ukuthatha i-Antioxidant kunye nomngcipheko weziganeko ezinxulumene nobudala benyukliya kwi-Beaver Dam Eye Study. NdinguJ Epidemiol 1999; 149: 801-9. Jonga i-abstract.
  228. UHankinson SE, uStampfer MJ, uSeddon JM, et al. Ukutya okunesondlo kunye nokukhutshwa kwe-cataract kubafazi: isifundo esinokwenzeka. BMJ 1992; 305: 335-9. Jonga i-abstract.
  229. ISeddon JM, Ajani UA, Sperduto RD, et al. I-carotenoids yokutya, iivithamini A, C, kunye no-E, kunye nokudodobala okuhambelana nobudala obuhambelana nobudala. Isifundo seLiso lokuLawulwa kwezifo zeSifo seLiso. IJAMA 1994; 272: 1413-20. Jonga i-abstract.
  230. I-Koonsvitsky BP, i-Berry DA, okqhubekayo. I-Olestra ichaphazela ukugxila kwe-serum ye-alpha-tocopherol kunye ne-carotenoids kodwa hayi ivithamin D okanye imeko ye-vitamin K kwizifundo zokuphila simahla. J Amanqatha 1997; 127: 1636S-45S. Jonga i-abstract.
  231. I-Kostic D, i-White WS kunye ne-Olson JA. Ukufakwa emathunjini, ukucoca i-serum, kunye nokunxibelelana phakathi kwe-lutein kunye ne-beta-carotene xa kulawulwa kubantu abadala ngokwahlukeneyo okanye ngokudibeneyo. NdinguJ J Clin Nutriti 1995; 62: 604-10. Jonga i-abstract.
  232. van den Berg H, van Vliet T.Iziphumo zexeshana, iidosi zomlomo ezizodwa ze-beta-carotene kunye ne-lutein okanye i-lycopene kwi-beta-carotene kunye neempendulo ze-retinyl ester kwiqhekeza elityebileyo le-lipoprotein eline-triacylglycerol. NdinguJ J Clin Nutr 1998; 68: 82-9. Jonga i-abstract.
  233. Umhlaba we-Landrum JT, uBone RA, uJoa H, et al. Isifundo sonyaka omnye se-macular pigment: isiphumo seentsuku ezili-140 zesongezelelo se-lutein. Ukucaciswa kwamehlo Res 1997; 65: 57-62. Jonga i-abstract.
  234. I-DM enobunzima. Ubungqina bokhuselo ngokuchasene nokudodobala kwe-macular ngokwe-carotenoids kunye neevithamini ze-antioxidant. NdinguJ J Clin Nutriti 1995; 62: 1448S-61S .. Jonga i-abstract.
  235. Spraycar M, ed. Isichazi-magama sikaStedman's Medical. Ngomhla wama-26. IBaltimore, MD: UWilliams kunye noWilkins, ngo-1995.
  236. Pratt S. Uthintelo lokutya lokudodobala okunxulumene nobudala be-macular. J Ndingu-Optom Assoc 1999; 70: 39-47. Jonga i-abstract.
  237. UBerson EL, uRosner B, uSandberg MA, et al. Uvavanyo olungenamsebenzi lwevithamini A kunye novithamin E wokuncedisa i-retinitis pigmentosa. IArch Ophthalmol 1993; 111: 761-72. Jonga i-abstract.
  238. I-CD yeNaylor, O'Rourke K, iDetsky AS, uBaker JP. Isondlo somzali nge-branched-chain amino acids kwi-hepatic encephalopathy. Uhlalutyo lweemeta. I-Gastroenterology 1989; 97: 1033-42. Jonga i-abstract.
  239. UMajumdar SK, uShaw GK, uThomson AD, et al. Utshintsho kwiipateni zeplasma zeamino acid kwizigulana ezinesifo esinganyangekiyo ngexesha lokurhoxa kwe-ethanol: iimpembelelo zazo zeklinikhi. Iingcamango ze-1983; 12: 239-51. Jonga i-abstract.
  240. UVorgerd M, uGrehl T, uJager M, et al. Ukuxhamla Yenza unyango kwi-myophosphorylase defence (isifo seMcArdle): ityala elilawulwa yi-placebo. IArch Neurol 2000; 57: 956-63. Jonga i-abstract.
  241. Foster S, uTyler VE. I-Herbal ethembekileyo yeTyler: Isikhokelo esiSebenzisayo sokuSebenzisa iiHerbs kunye neZonyango ezinxulumene noko. I-3rd ed., IBinghamton, NY: I-Haworth Herbal Press, ngo-1993.
  242. INewall CA, uAnderson LA, uPhilpson JD. Unyango ngamayeza esintu: Isikhokelo saBasebenzi bezeMpilo. ILondon, e-UK: Icandelo leendaba lonyango, ngo-1996.
  243. UTyler VE. IiHerbs zoKhetho. I-Binghamton, NY: Imveliso yezeMveliso yezeMveliso, ngo-1994.
  244. Blumenthal M, ed. IKhomishini epheleleyo yaseJamani i-E Monographs: Isikhokelo sonyango kumaYeza eHerbal. Dlulisa. S. Klein. IBoston, MA: IBhunga laseMelika leBhotani, i-1998.
  245. Monographs ekusebenziseni amayeza iziyobisi zezityalo. I-Exeter, e-UK: I-European Scientific Co-op Phytother, ngo-1997.
Ukuhlaziywa okokugqibela-02/23/2021

Qiniseka Ukuba Ufunda

Yonke into ekufuneka uyazi ngeeShellac Nails kunye nezinye iiGel Manicure
Indlela Yokuphila

Yonke into ekufuneka uyazi ngeeShellac Nails kunye nezinye iiGel Manicure

Emva kokuba ufumene inca a yejeli ye-nail poli h, kunzima ukubuyela kwipeyinti eqhelekileyo. I-manicure engenaxe ha elomileyo engayi kukhwela iiveki kunzima ukuyiyeka. Ngetham anqa, phant e yonke i- a...
Kutheni uFantasy wakho weSini weGym esiqhelo ngokwesiqhelo (kwaye yintoni onokuyenza ngayo)
Indlela Yokuphila

Kutheni uFantasy wakho weSini weGym esiqhelo ngokwesiqhelo (kwaye yintoni onokuyenza ngayo)

Uku ebenza nzima ngetayitile yokunyathela ngenye imini, uthi krwaqu kwigumbi ukuze ubone umntu o hu hu o hu hu kumgangatho wobunzima ejonge indlela yakho. Amehlo akho adibana kwaye uva ubu hu hu bunyu...